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ABSTRACT  
Arsenic is a common poison and is classified as human carcinogen. Selenium is an essential 
nutrient, but is highly toxic when applied in high concentrations. The cytotoxic potential of 
both metalloids is modified when they form sulfur-containing complexes. For arsenic 
compounds, only some data existed about the bioavailability and cytotoxicity of methylated 
thioarsenates. No data existed about inorganic thioarsenates, even though their formation 
during pre-systemic arsenic metabolism was already proven. For selenium compounds, a 
reported general higher cytotoxicity of selenosulfate compared to selenite for cancer cell 
lines led to the claim of replacing selenite by selenosulfate in anti-cancer therapies.  
In the first two studies of the present thesis, intestinal transport (e.g. bioavailability), cellular 
retention, and cytotoxicity of thioarsenates were investigated. The cellular retention and the 
intestinal transport of synthesized standard solutions of methylated and inorganic 
thioarsenates were compared to those of their non-thiolated analogues by means of a model 
of the human small intestine (Caco-2 cell monolayer). Analyses with AEC-ICP-MS were 
conducted to monitor species stability during the transport experiments. Both the 
transcellular uptake route (by phosphate transporters) and the paracellular uptake route 
(through the tight junctions) were investigated for each arsenic species. 
The influence of sulfide on arsenite was investigated concerning the formation of inorganic 
thioarsenates and an accordingly modified cytotoxicity, quantified by means of MTT assay. 
The cytotoxic effects of arsenite, arsenate, and inorganic thioarsenates were compared for 
human hepatocytes (HepG2) and urothelial cells (UROtsa). Concentrations of each arsenic 
species leading to 50 % cell viability (IC50 values) were calculated. Cellular uptake of the 
different inorganic arsenic compounds was quantified and linked to their cytotoxicity. 
As expected, arsenite showed the highest cellular retention and intestinal transport of all 
tested arsenic compounds. The bioavailability of thioarsenates strongly differed from that of 
their non-thiolated analogues. For dimethylmonothioarsenate, the highest cellular retention 
and intestinal transport among all methylated arsenic compounds were measured, which is 
of special concern as this species is known to possess a considerably higher cytotoxicity 
than its non-thiolated analogue dimethylarsenate. Only low cellular retention – comparable to 
that of arsenate - was detected for the inorganic thioarsenates mono- and trithioarsenate, but 
their intestinal transport was considerably higher than that of arsenate. For trithioarsenate, 
the intestinal transport was even comparable to that of arsenite. Mono- and trithioarsenate 
were transported intact through the cell monolayer, but partial intracellular reduction to 
arsenite could not be excluded. Both cellular retention and intestinal transport was negligibly 
low for mono- and dimethylarsenate and for monomethylmonothioarsenate. The absence of 
phosphate increased cellular retention of all arsenic compounds indicating the importance of 
apical phosphate transporters. No data could be presented to interpret the importance of the 
ABSTRACT 
 
VIII 
 
paracellular transport route as the cell monolayer was damaged during these experiments. 
Addition of sulfide to arsenite-containing cell growth medium resulted in immediate formation 
of inorganic thioarsenates and in reduced cytotoxicity. The order of cytotoxicity of the 
individually applied inorganic arsenic compounds after 24 h exposure was determined as 
arsenite > trithioarsenate > monothioarsenate > arsenate and this corresponded to the order 
of cellular arsenic uptake. Considering arsenite as the original present arsenic substrate for 
the formation of inorganic thioarsenates, thiolation can be seen as a detoxification process 
due to decreased intestinal transport and cytotoxicity. In case of dimethylmonothioarsenate, 
which is known to form from dimethylarsenate, thiolation can be seen as an activation 
process due to increased intestinal transport and cytotoxicity. 
In the third study, cytotoxic effects and cellular uptake of selenosulfate and selenite were 
compared for three different cancer cell lines (HepG2, A375, and T24) to reassess the claim 
of selenosulfate being generally more cytotoxic than selenite for cancer cells. Experiments in 
absence and presence of amino acids linked the influence of amino acids with the 
cytotoxicity of the selenium compounds. 
Selenosulfate was comparably toxic to the three cell lines (IC50 6.6-7.1 µM) and hardly 
influenced by incubation time and presence or absence of amino acids. Though, selenite 
cytotoxicity considerably differed among the three cell lines with the result that selenosulfate 
was more toxic than selenite for HepG2 cells (IC50 > 15 µM), but similar toxic to and lower 
toxic than selenite for A375 (IC50 4.7 µM) and T24 cells (IC50 3.5 µM). 
In contrast to T24 cells, HepG2 cells were “routinely” cultivated with amino acids. Addition of 
amino acids to T24 cell growth medium led to reduced selenite uptake and toxicity, rendering 
it less toxic than selenosulfate. The strong effect of amino acids on selenite toxicity for T24 
cells could be explained by an inhibition of the xc- transport system which facilitates cellular 
selenium uptake by secretion of cysteine and reduction of selenium compounds. 
Selenosulfate is less affected by the addition of amino acids as it is already a reduced 
species. Whether selenosulfate or selenite is more cytotoxic, does not only depend on the 
selenium species itself, but also on the sensitivity of the used cell line, the supplements of 
the cell growth medium, and the reductive state of the extracellular environment. The general 
claim of selenosulfate being more toxic than selenite therefore has to be reconsidered.
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ZUSAMMENFASSUNG 
Arsen ist ein bekannter Giftstoff und für den Menschen als kanzerogen eingestuft. Selen ist 
ein essentieller Nährstoff, jedoch äußerst toxisch in hoher Konzentration. Die Zytotoxizität 
beider Halbmetalle ändert sich, wenn sie Komplexe mit Schwefel bilden. Über die 
Bioverfügbarkeit und Zytotoxizität von methylierten Thioarsenaten gab es bisher nur wenige 
und über die von anorganischen Thioarsenaten gar keine Daten, obwohl deren Bildung 
während der präsystemischen Arsen-Metabolisierung bereits bewiesen wurde. Selenosulfat 
galt generell als zytotoxischer für Krebszellen als Selenit. Daraus entstand der Vorschlag, 
dass Selenosulfat Selenit in der Krebstherapie ersetzen sollte.  
In den beiden ersten Studien der vorliegenden Arbeit wurden die intestinale Absorption (d.h. 
die Bioverfügbarkeit), die zelluläre Retention und die Zytotoxizität von Thioarsenaten 
untersucht. Mit Hilfe eines Modell für den menschlichen Dünndarm (Caco-2-Zellmodell) 
wurden die zelluläre Retention und die intestinale Absorption von synthetisierten 
Standardlösungen von methylierten und anorganischen Thioarsenaten mit denen ihrer nicht-
thiolierten Strukturanaloge verglichen. Die Stabilität der einzelnen Verbindungen während 
der Transportexperimente wurde durch AEC-ICP-MS Analysen beurteilt. Sowohl der 
transzelluläre Aufnahmeweg (durch Phosphat-Transporter) als auch der parazelluläre 
Aufnahmeweg (durch die Tight Junctions) wurden für jede Arsen-Verbindung untersucht.  
Der Einfluss von Schwefel auf Arsenit wurde im Hinblick auf die Bildung von anorganischen 
Thioarsenaten und die daraus resultierende geänderte Zytotoxizität untersucht (gemessen 
mit dem MTT Test). Die zytotoxischen Effekte von Arsenit, Arsenat und den anorganischen 
Thioarsenaten wurden für eine menschliche Leberkrebszelllinie (HepG2) und eine 
Blasenzelllinie (UROtsa) verglichen. Von jeder Arsen-Verbindung wurde die Konzentration 
berechnet, die zu einer Reduktion der Zellviabilität um 50 % führte (IC50 Wert). Die zelluläre 
Aufnahme jeder anorganischen Arsenverbindung wurde quantifiziert und mit ihrer jeweiligen 
Zytotoxizität in Verbindung gebracht.  
Die höchste zelluläre Retention und intestinale Absorption wurde erwartungsgemäß für 
Arsenit gemessen. Die Bioverfügbarkeit von Thioarsenaten unterschied sich deutlich von der 
ihrer nicht-thiolierten Analoge. Unter allen methylierten Arsenverbindungen wurden die 
höchste zelluläre Retention und intestinale Absorption für Dimethylmonothioarsenat 
bestimmt. Dies ist besonders bemerkenswert, denn diese Verbindung besitzt eine deutlich 
höhere Zytotoxizität als ihr nicht-thioliertes Strukturanalog Dimethylarsenat. Die zelluläre 
Retention der anorganischen Thioarsenate Mono- und Trithioarsenat war vergleichbar gering 
mit der von Arsenat. Ihre intestinale Absorption war aber deutlich höher als die von Arsenat, 
für Trithioarsenat sogar vergleichbar mit der von Arsenit. Mono- und Trithioarsenat wurden 
intakt durch die Zellschicht transportiert, allerdings konnte eine teilweise intrazelluläre 
Reduktion zu Arsenit nicht ausgeschlossen werden. Die zelluläre Retention und die 
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intestinale Absorption von Mono- und Dimethylarsenat und von Monomethylmonothioarsenat 
waren vernachlässigbar gering. In Abwesenheit von Phosphat nahm die zelluläre Retention 
aller Arsen-Verbindungen zu, was auf die Bedeutung von apikalen Phosphat-Transportern 
hinweist. Es konnten keine Daten über die Bedeutung des parazellulären Transportweges 
erhoben werden, weil während dieser Experimente die Zellschicht beschädigt wurde.  
Sulfid-Zugabe in das Zellkulturmedium, das Arsenit enthielt, führte zur sofortigen Bildung von 
anorganischen Thioarsenaten und zu reduzierter Zytotoxizität. Die Toxizitäts-Reihenfolge der 
einzelnen anorganischen Arsenverbindungen nach 24 h Inkubation war Arsenit > Trithio-
arsenat > Monothioarsenat > Arsenat. Die gleiche Reihenfolge wurde auch für die zelluläre 
Aufnahme bestimmt. Unter der Annahme, dass anorganische Thioarsenate direkt aus 
Arsenit gebildet werden, kann Thiolierung als ein Prozess der Detoxifikation beschrieben 
werden, da dadurch die intestinale Absorption und die Zytotoxizität reduziert werden. Im Fall 
von Dimethylmonothioarsenat, das aus Dimethylarsenat gebildet wird, kann Thiolierung 
allerdings als ein Aktivierungsprozess beschrieben werden, da dadurch die intestinale 
Absorption und die Zytotoxizität gesteigert wird.  
In der dritten Studie wurden die zytotoxischen Effekte und die zelluläre Aufnahme von 
Selenosulfat und Selenit für drei verschiedene Krebszelllinien (HepG2, A375 und T24) 
verglichen, um die Behauptung zu überprüfen, dass Selenosulfat generell zytotoxischer auf 
Krebszellen wirkt als Selenit. Experimente mit und ohne Aminosäuren untersuchten deren 
Einfluss auf die Zytotoxizität der Selenverbindungen.  
Die Zytotoxizität von Selenosulfat war für alle drei Zelllinien vergleichbar (IC50 6.6-7.1 µM) 
und größtenteils unbeeinflusst durch die Faktoren Inkubationszeit und Aminosäuren. 
Allerdings war die Zytotoxizität von Selenit für die drei Zelllinien sehr unterschiedlich, was 
dazu führte, dass Selenosulfat toxischer als Selenit für HepG2 war (IC50 > 15 µM), aber 
vergleichbar toxisch mit bzw. weniger toxisch als Selenit für A375 (IC50 4.7 µM) und T24 
Zellen (IC50 3.5 µM). Im Gegensatz zu den T24 Zellen wurden die HepG2 Zellen 
routinemäßig mit Aminosäuren kultiviert. Durch die Zugabe von Aminosäuren zum T24 
Zellkulturmedium wurden Selenitaufnahme und -toxizität dermaßen reduziert, dass 
Selenosulfat für T24 Zellen toxischer war als Selenit. Der starke Einfluss von Aminosäuren 
auf die Selenit-Toxizität für T24 Zellen könnte durch eine Hemmung des xc-- 
Transportsystems erklärt werden, welches die zelluläre Selenaufnahme durch Exkretion von 
Cystein und Reduktion der Selenverbindung steuert. Selenosulfat ist durch die Aminosäuren 
wenig beeinflusst, da es bereits reduziert ist. Ob Selenosulfat oder Selenit zytotoxischer ist, 
hängt nicht nur von der Selenverbindung selbst ab, sondern auch von der Empfindlichkeit 
der verwendeten Zelllinie, den einzelnen Bestandteilen des Zellkulturmediums und den 
reduktiven Bedingungen in der extrazellulären Umgebung. Die generelle Behauptung, dass 
Selenosulfat toxischer als Selenit ist, muss deswegen überdacht werden. 
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EXTENDED SUMMARY 
1 INTRODUCTION 
1.1 Toxicity of arsenic and selenium 
Arsenic is a widespread environmental contaminant in water, soil, and food and it is 
classified as carcinogen. Besides numerous harmful health effects, chronic exposure to 
arsenic is associated with cancer of bladder, liver, skin, and other organs (reviewed in Bates 
et al. (1992)). In drinking water, the trivalent arsenite (H3AsIIIO3) and the pentavalent arsenate 
(H3AsVO4) are the dominant arsenic species (Smedley & Kinniburgh 2002) (Figure 1). 
According to laboratory studies with animals and cell cultures, trivalent arsenic species are 
considerably more toxic than pentavalent arsenic species (Thomas et al. 2001). 
 
Figure 1: Chemical structures of arsenite and arsenate – the main arsenic species in water. 
 
Ingested arsenic in form of arsenite or arsenate is metabolized into methylated arsenic 
compounds. The Challenger mechanism was the first widely accepted metabolism pathway 
for inorganic arsenic species in the body. It implicates alternating steps of reduction 
(catalyzed by the enzyme MMAV reductase) and oxidative methylation leading to 
dimethylated arsenic compounds (Challenger 1945, Le et al. 2000, Vahter 1999). However, 
several other studies showed that the Challenger mechanism has to be reconsidered due to 
the following findings:  
1) In MMAV reductase deficient mice, arsenate metabolism did not significantly differ 
from arsenate metabolism in wild type mice (Chowdhury et al. 2006). 
2) Pentavalent species were metabolized into trivalent species only to a considerably 
smaller extent than proposed by the Challenger mechanism (Cohen et al. 2006). 
3) After ingestion, monomethylarsenate (MMAV) and dimethylarsenate (DMAV) are 
immediately excreted into urine and are not reduced into their trivalent analogues. 
The pentavalent species can therefore rather be regarded as end-products and not 
as intermediates during arsenic biotransformation (Marafante et al. 1987, Yamauchi & 
Yamamura 1984). 
 
Subsequently, a further arsenic metabolism pathway was suggested by Hayakawa and co-
workers (Hayakawa et al. 2005). These researchers suggested that ingested arsenate is 
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reduced to arsenite, which subsequently forms complexes with glutathione. These 
complexes are enzymatically methylated resulting in the formation of MMAIII and DMAIII. The 
end-products MMAV and DMAV are formed by oxidation of MMAIII and DMAIII, respectively.  
Naranmandura and co-workers proposed a metabolism pathway similar to that of Hayakawa 
and co-workers, but suggested the presence of different arsenic-protein-complexes as 
substrates for methylation which are subsequently oxidized (Rehman & Naranmandura 
2012).  
The exact mechanisms of arsenic metabolism are not fully clarified yet. Anyway, both 
trivalent and pentavalent methylated species can be present in the body after arsenic 
ingestion (Petrick et al. 2001). Formation of pentavalent methylated arsenic species during 
arsenite or arsenate metabolism presents a process of detoxification, but formation of 
trivalent methylated arsenic species results in a substantial increase of toxicity compared to 
arsenite or arsenate and can therefore be regarded as activation process (Styblo et al. 
2002).  
Three different mechanisms of arsenic toxicity leading to the development of cancer are 
widely accepted (Kitchin 2001): Production of chromosomal abnormalities by induction of 
chromosomal breakages, alteration of growth factors and cell proliferation, and the induction 
of oxidative stress in cells. Induction of oxidative stress by arsenic can either arise from 
arsenic-induced generation of reactive oxygen species (Eblin et al. 2006) or from the 
depletion of antioxidant enzymes or glutathione in the cell (Radabaugh & Aposhian 2000, 
Tabacova et al. 1994, Zakharyan & Aposhian 1999).  
 
In contrast to arsenic, selenium is an essential nutrient (Schwarz & Foltz 1957) and can have 
an anti-carcinogenic and anti-mutagenic effect in low concentrations. But in higher doses it 
can have toxic, carcinogenic, and mutagenic effects (Bronzetti et al. 2001). In comparison to 
other micronutrients, the concentration range between beneficial and toxic effects after 
ingestion of selenium is quite narrow (Letavayova et al. 2008). Inorganic selenium exists in 
the oxidation states +4 as selenite (H2SeIVO3), +6 as selenate (H2SeVIO4) (Figure 2), and 0 as 
elemental selenium. In food, selenium is mostly incorporated in selenoenzymes, e.g. in form 
of the amino acids selenomethionine and methylselenocysteine (Figure 2) (Letavayova et al. 
2008). Numerous studies report beneficial properties of selenium such as inactivating toxic 
metals (Hansen 1988), neutralizing free radicals (Borek et al. 1986), and antioxidant effects 
of selenoenzymes (Burk 1990, Irion 1999). Most selenium-related toxicological studies were 
conducted with selenite (Brozmanova et al. 2010). Applied in high doses it has been shown 
to exert strong cytotoxic effects, e.g. on prostate (Li et al. 2007), ovarian (Park et al. 2012a), 
liver (Shen et al. 1999), or lung cells (Park et al. 2012b). The toxic effects of selenium 
compounds are not fully understood, yet. But the induction of DNA damage due to double-
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strand breakages (Biswas et al. 2000, Letavayova et al. 2008), oxidative stress (Wycherly et 
al. 2004, Zou et al. 2007), and apoptosis (Shen et al. 1999) by selenium were reported. 
Based on existing toxicological data, selenium is not classified as human carcinogen 
(Valdiglesias et al.).  
 
 
Figure 2: Chemical structures of selenite and selenate and selenomethionine and methylselenocysteine – 
two selenium-containing amino acids. 
 
1.2 Arsenic-sulfur species: Thioarsenates 
1.2.1 Occurrence and formation of thioarsenates in biological systems  
For a long time, arsenite and arsenate were assessed to be the two main inorganic species 
that are present in arsenic-rich waters (Cullen & Reimer 1989). By now, it is known that in 
sulfidic environments, occurrence of arsenic is predominated by inorganic thioarsenic 
species which crucially influence arsenic chemistry (Hollibaugh et al. 2005, Planer-Friedrich 
et al. 2007, Stauder et al. 2005, Wilkin et al. 2003). These species were shown to form under 
abiotic and reducing conditions by mixing arsenite and sulfide (Wilkin et al. 2003). It was 
controversially discussed whether these species are trivalent thioarsenites (AsIIISnO3-n with n 
= 1-3) or pentavalent thioarsenates (AsVSnO4-n with n = 1-4). Based on geochemically 
expectations, trivalent thioarsenites were assumed to form as the species were detected 
under anoxic conditions (Beak et al. 2008, Bostick et al. 2005, Helz et al. 1995, Wood et al. 
2002). But chromatographic analyses using anion-exchange chromatography-inductively 
coupled plasma-mass spectrometry (AEC-ICP-MS) and electrospray ionization tandem mass 
spectrometry (ESI-MS-MS) identified these species as pentavalent thioarsenates. X-ray 
absorption spectroscopy (XAS) data confirmed the presence of thioarsenates in these 
solutions and identified thioarsenites as precursors of thioarsenate formation (Planer-
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Friedrich et al. 2010). Mixing sulfide and arsenite at high SH-/OH- ratio under anoxic 
conditions leads to formation of mono-, di-, and trithioarsenite (MTAIII, DTAIII, and TTAIII) 
which are immediately oxidized either directly by addition of elemental sulfur (S0) or indirectly 
by O2 addition which oxidizes sulfide to S0, both resulting in the formation of di-, tri-, and 
tetrathioarsenate (DTAV, TTAV, and TetraTAV). Monothioarsenate (MTAV) is spontaneously 
formed from arsenite by addition of elemental sulfur (low SH-/OH- ratio) (Figure 3). 
 
 
Figure 3: Reaction pathway of thioarsenite and thioarsenate formation according to Planer-Friedrich et al. 
(2015); the blue arrows indicate spontaneous reactions, the green dashed arrows indicate slow reactions 
that need an additional reactant like O2, H2O2, or H+; monothioarsenate is spontaneously formed from 
arsenite by addition of zerovalent sulfur (low SH-/OH- ratio) and is kinetically stable; the occurrence of 
mono- and dithioarsenite during this metabolism pathway is only postulated, whereas trithioarsenite was 
detected by XAS and all thioarsenates were detected by AEC-ICP-MS. 
 
Acidification of DTAV, TTAV, and TetraTAV leads to arsenite formation, whereas MTAV is 
stable under acidic conditions (Planer-Friedrich et al. 2010). Basically, thioarsenites cannot 
be detected by chromatographic methods to date as they are extremely sensitive towards the 
presence of oxygen. Even smallest amounts of oxygen are sufficient for immediate oxidation 
and high concentrations of OH- groups in the eluent lead to immediate transformation of 
thioarsenites into arsenite (Planer-Friedrich et al. 2010). 
Formation of thioarsenates is not only important in respect to arsenic behavior in the 
environment, but can crucially influence the behavior of arsenic in the body after ingestion.  
Reduction and methylation during arsenic metabolism are long-known processes and it is 
estimated that 50-70 % of ingested inorganic arsenic - depending on the studied organism - 
is rapidly reduced to arsenite and subsequently methylated to dimethylated arsenic 
compounds which are detected in urine (Vahter 1999). High amounts of free sulfide in the 
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human gut and high pH (Jorgensen & Mortensen 2001) facilitate the formation of 
thioarsenates after arsenite intake. The presence of aerobic microbiota - even if they present 
the minority group of all microbiota present in the human intestine (Ramakrishna 2007) - 
reveals that thioarsenites do not have to be considered in terms of arsenic-sulfur speciation 
in the intestine due to immediate oxidation. The presence of thiolated arsenic compounds in 
biological samples was proven in several studies implying the need to consider these 
compounds in pre-systemic arsenic metabolism and arsenic risk assessments:  
Yoshida and co-workers detected an unknown sulfur-containing arsenic metabolite – 
presumably the same metabolite that was already reported by Hughes and Kenyon (1998) - 
in rat urine and feces after exposure to DMAV (Yoshida et al. 2003). This metabolite was 
formed by Escherichia coli strain A3-6 that was isolated from the ceca of DMAV exposed rats 
(Yoshida et al. 2003). The mechanism of the arsenic-sulfur-metabolite formation was 
reported to be reduction of DMAV to DMAIII followed by thiolation. Oxidation of the unknown 
metabolite resulted in DMAV formation. Therefore, Yoshida and co-workers deduced it to be 
a trivalent DMAIII derivative. By analyses with HPLC-ICP-MS coupled simultaneously to 
electrospray mass spectrometry and electrospray ionization quadrupole time-of-flight mass 
spectrometry, Hansen and co-workers could show later that this metabolite – formed as main 
product during DMAV reduction with sodium-metabisulfite (Na2S2O5)/sodium thiosulfate 
(Na2S2O3) reagent – was not a trivalent, but a pentavalent sulfur-containing DMAV derivate, 
namely dimethylmonothioarsenate (DMMTAV). The structure was additionally confirmed by 
proton nuclear magnetic resonance analyses. In the same study (Hansen et al. 2004), 
DMMTAV could be detected in urine and in wool extract from sheep that were naturally 
exposed to high concentrations of arsenosugars in their food. This study was the first that 
could distinctly identify thioarsenates in a biological sample.  
Subsequently, several studies detected DMMTAV after arsenic exposure in urine of hamsters 
(Naranmandura et al. 2007b), rats (Adair et al. 2007, Naranmandura et al. 2007b), and mice 
(Hughes et al. 2008), in urine of DMAV-exposed hamsters, monomethylmonothioarsenate 
(MMMTAV) was also detected (Naranmandura et al. 2007b). Furthermore, DMMTAV was also 
shown to be a common arsenic metabolite in urine of women in Bangladesh who were 
exposed to arsenic (Raml et al. 2007).  
Microbial thiolation of DMAV leading to DMMTAV and DMDTAV formation was observed by 
Kubachka and co-workers (Kubachka et al. 2009): During incubation with microbiota from 
mouse cecum DMAV was metabolized to DMMTAV and dimethyldithioarsenate (DMDTAV), 
and also to monothiotrimethylarsenate (MTTMAV). Based on their results, Kubachka and co-
workers proposed a scheme for DMAV biotransformation leading to sulfur-containing 
metabolites. Either DMAV is directly thiolated leading to formation of DMMTAV and DMDTAV 
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or DMAV is first reduced to DMAIII which is subsequently methylated (formation of 
trimethylarsenate) and finally thiolated (formation of MTTMAV) (Figure 4). 
 
 
Figure 4: Formation of methylated thioarsenicals by microbiota of mouse cecum incubated with DMAV. 
DMMTAV and DMDTAV are formed by thiolation of DMAV, MTTMAV is formed via DMAV methylation 
followed by thiolation; scheme proposed by Kubachka et al. (2009). 
 
Incubating human gut microbiota with arsenate resulted in the formation of methylated 
arsenic compounds (MMAV and MMAIII), methylated thioarsenic compounds (MMMTAV) and 
interestingly also in one inorganic thioarsenic compound (MTAV) (Van de Wiele et al. 2010). 
Formation of inorganic thioarsenates by gut microbiota was confirmed in another study with 
microbiota from mouse ceca that were incubated with arsenate. The formation of seven 
different metabolites was observed: Besides the original substrate arsenate, methylated and 
inorganic thioarsenic species were detected in the reaction mixtures (Pinyayev et al. 2011). 
Pinyayev and co-workers proposed a scheme for the metabolism of arsenate: Alternating 
steps of reduction and oxidative methylation lead to the formation of arsenite, MMAV, MMAIII, 
DMAV, DMAIII, and trimethylarsenate (TMAV). Each pentavalent species present can 
subsequently be reversibly thiolated leading to the formation of Mono-, Di-, Tri-, and 
TetraTAV (formed by thiolation of arsenate), MMMTAV, MMDTAV, and MMTTAV (formed by 
thiolation of MMAV), and DMMTAV, DMDTAV (formed by thiolation of DMAV), and TMMTAV 
(formed by thiolation of TMAV) (Figure 5). Pinyayev and co-workers also suggest the 
presence of trivalent intermediates (inorganic and methylated thioarsenites) in terms of their 
arsenate metabolism scheme. It is not clear why Pinyayev and co-workers did not detect any 
arsenite or DMMTAV in their experiments as it was shown in the mentioned study from 
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Kubachka et al. (2009). Other studies disagree with the presented scheme as direct 
thiolation of pentavalent arsenic species was shown to occur only at pH < 4 for both arsenate 
(Planer-Friedrich et al. 2015) and methylated pentavalent arsenic species (Rochette et al. 
2000) and support the hypothesis that pentavalent arsenic species have to be reduced prior 
to thiolation. However, in contrast to these observations from abiotic systems, it cannot be 
excluded that gut microbiota are able to directly thiolate pentavalent arsenic compounds also 
at near-neutral pH.  
In summary, the conditions in the human gut – free sulfide and high pH - definitely facilitate 
thioarsenate formation after arsenite or arsenate ingestion, but the exact mechanisms of their 
formation remain to be completely elucidated. Both methylated and inorganic thioarsenates 
were already detected during pre-systemic metabolism. What is primarily missing, is any 
information about the ability of thioarsenates to pass the gastrointestinal barrier without 
changing their speciation and about the subsequent relevance of their toxicity for organs.  
 
 
Figure 5: Arsenate metabolism by microbiota of mouse cecum; by alternating steps of reduction and 
oxidative methylation arsenate is metabolized firstly into arsenite and then into methylated pentavalent 
and trivalent arsenic compounds; each pentavalent compound can subsequently be thiolated leading to 
the formation of inorganic and methylated thioarsenic species. Scheme proposed by Pinyayev and co-
workers (2008). The suggested presence of trivalent intermediates (inorganic and methylated 
thioarsenites) is not considered in this figure. 
INTRODUCTION: Arsenic-sulfur species: Thioarsenates 
 
- 8 - 
 
1.2.2 Bioavailability of arsenic species determined by transport through a 
Caco-2 cell monolayer 
Bioavailability is defined as the fraction of a compound that reaches the systemic circulation 
after ingestion and digestion in the gastrointestinal tract. Besides their formation during pre-
systemic arsenic metabolism and their cytotoxicity potential towards different cell lines, it is 
primarily the bioavailability of each arsenic species – i.e. the intestinal transport – which 
determines the toxic potential of a single arsenic species. Moreover, bioavailability is the 
crucial factor that makes toxicity studies of the respective compound relevant at all. 
Compared to toxicity studies, even less studies about the bioavailability of thioarsenates 
have been published so far.  
The Caco-2 cell line is an immortalized cell line of heterogeneous human epithelial colorectal 
adenocarcinoma cells. After differentiation, their morphological and functional characteristics 
were shown to be very similar to those of small-intestine enterocytes (Hidalgo et al. 1989, 
Pinto et al. 1983). Most intestinal absorption takes places at the small intestines and so the 
Caco-2 cell line is suitable for laboratory studies to investigate the intestinal absorption 
behavior and transport mechanisms of different compounds.  
In general, two mechanisms can facilitate the transport of arsenic compounds in the cells: 
The paracellular transport mechanism via the tight junctions of the cells and the transcellular 
pathway via membrane-located transport systems that are generally assumed to be 
phosphate transporters (Figure 6). 
 
 
Figure 6: Paracellular and transcellular transport route in apical-basal direction through a Caco-2 cell 
monolayer. 
 
Inhibited transport of a compound in presence of an excess phosphate concentration 
indicates the involvement of membrane-located phosphate transporters in transporting this 
compound. Increased transport of a compound by the addition of ethylenediaminetetraacetic 
acid (EDTA), which removes calcium and magnesium ions and therefore opens the tight 
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junctions, indicates the involvement of a paracellular transport system (Calatayud et al. 2011, 
Calatayud et al. 2010). 
Concerning the arsenic species that are relevant for the present thesis, bioavailability studies 
using the Caco-2 cell line as model for the human small intestines were already published for 
arsenite, arsenate, MMAIII, MMAV, DMAIII, DMAV, and DMMTAV (Calatayud et al. 2011, 
Calatayud et al. 2010, Laparra et al. 2005). 
Intestinal transport of arsenite (5.82 ± 7.71 %) was more efficient than that of arsenate (not 
detectable). Also cellular retention of arsenic was more pronounced for arsenite (0.87 – 
2.28 %) than for arsenate (0.14-0.39 %) (Laparra et al. 2005). Further studies could show 
that both the cellular retention and intestinal transport of trivalent species (arsenite, MMAIII, 
DMAIII) were higher compared to their pentavalent analogues (arsenate, MMAV, DMAV) 
(Calatayud et al. 2011, Calatayud et al. 2010). 
Comparing the intestinal transport of the pentavalent species, MMAV and DMAV showed 
lower intestinal transport than arsenate (Calatayud et al. 2010). In contrast, comparing the 
intestinal transport of the trivalent species, MMAIII and DMAIII showed higher intestinal 
transport than arsenite (Calatayud et al. 2011) and the rate of transport was proportional to 
the degree of methylation (DMAIII > MMAIII > arsenite). The involvement of a paracellular 
transport component (via the tight junctions) was shown for arsenite, arsenate, MMAIII, 
MMAV, and DMAV, whereas DMAIII was not transported via the paracellular route (Calatayud 
et al. 2011, Calatayud et al. 2010). Intestinal transport of arsenate was significantly inhibited 
by the addition of phosphate, indicating that phosphate transporters of the cellular membrane 
are involved in the intestinal transport of arsenate (Calatayud et al. 2010). The intestinal 
transport of DMMTAV is of special concern due to its relatively high toxicity. A recent study 
could show that the transport of DMMTAV is as high as that of arsenite (Leffers et al. 2013b). 
These data indicate that thiolation of arsenic compounds does not only have significant 
influence on their toxicity but also on their bioavailability. As studies about the intestinal 
transport of methylated thioarsenates are scarce and no study at all existed about the 
intestinal transport of inorganic thioarsenates, study 1 of the present thesis focusses on the 
intestinal transport of methylated and inorganic thioarsenates. 
 
1.2.3 Toxicity of thioarsenates 
For inorganic thioarsenates, the only toxicological data present until the publication of study 
2, which is included in this thesis, are based on experiments with the marine luminescent 
bacteria Vibrio Fischeri (Planer-Friedrich et al. 2008, Rader et al. 2004). Even if these data 
are not directly transferable to arsenic toxicity to humans, they clearly indicate that thiolation 
has a distinct influence on arsenic toxicity. Rader and co-workers reported a significant 
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decrease of arsenite toxicity in the presence of sulfide. A further study repeated these 
experiments with concurrent arsenic speciation analyses and attributed the decrease of 
arsenic toxicity to the formation of thioarsenates (Planer-Friedrich et al. 2008). In this study, 
additional experiments with synthesized thioarsenate standards were performed. Whereas 
MTAV and DTAV were found to be significantly less toxic than arsenite, TTAV showed 
comparable toxicity.  
The toxicity of different methylated thioarsenates substantially differs from each other. 
Naranmandura and co-workers reported the order of toxicity of eight different arsenic 
compounds for the human bladder cell line EJ-1 as DMAIII, DMMTAV > arsenite, arsenate 
>MMMTAV > MMAV, DMAV, and DMDTAV (Naranmandura et al. 2011). In another study from 
Naranmandura and co-workers using the human epidermoid carcinoma cell line A431, 
DMMTA(V) was shown to exhibit slightly lower acute cytotoxicity (IC50 5.7 µM) than arsenite 
(Naranmandura et al. 2007a). Therefore, MMMTAV is slightly more toxic than the methylated 
arsenic compounds MMAV and DMAV but still less toxic compared to arsenite or arsenate and 
DMDTAV is assessed to be an arsenic species of comparably low toxicity. 
An arsenic species of special concern is DMMTAV: It was already reported to be substantially 
more toxic than DMAV (Ochi et al. 2008, Yoshida et al. 2003) and further studies even 
showed that its toxicity clearly exceeded that of arsenite (Leffers et al. 2013a). The difference 
in toxicities between DMMTAV and arsenite could be traced back to different intracellular 
mechanisms. While DMMTAV exposure led to reduced expression of p21 and p53 proteins, 
DNA damage, reduced glutathione level, and increased level of highly reactive oxygen 
species, arsenite exposure resulted in increased expression of p21 and p53 proteins, but 
glutathione and highly reactive oxygen levels remained unaffected (Naranmandura et al. 
2011). The exact mechanisms explaining the toxicities of all different arsenic compounds are 
not clarified, yet.  
Taken together, several studies exist that compare the cytotoxicity of arsenite, arsenate, (see 
Paragraph 1.1), and methylated thioarsenates. Studying the cytotoxicity of inorganic 
thioarsenates was one focus of the present thesis (study 2). 
 
1.3 Selenium-sulfur species: Selenosulfate 
The inorganic selenium-sulfur complex selenosulfate is a structural analogue to sulfate with 
one oxygen atom replaced by a sulfur atom (Figure 7). It is used for the industrial preparation 
of nanoparticles of different selenium compounds, e.g. cadmium selenide or silver selenide 
(Pejova et al. 2000, Raevskaya et al. 2006). Occurrence of selenosulfate was detected in 
flue gas desulfurization water (Petrov et al. 2012) and in root exsudates of selenite-exposed 
Indian Mustard (Mounicou et al. 2006, Vonderheide et al. 2006). In general, hardly any 
studies exist investigating the chemical properties and toxicological potential of selenosulfate 
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to date. The anticarcinogenic property of selenium was first suggested in the 1960s by 
Shamberger and Frost (1969) who reported an inverse relationship between cancer mortality 
rates and the concentration of selenium in forage crop in the USA. Subsequently, several 
studies confirmed that selenium compounds possess anticarcinogenic properties (reviewed 
in Combs and Gray (1998), Rayman (2005)). Several mechanisms that account for the 
anticarcinogenic properties of selenium are suggested, like an antioxidative effect and the 
control of the cellular redox state by various selenoenzymes, reduction of DNA damage, 
reduction of tumor promoting inflammation, or induction of apoptosis (reviewed in Rayman 
(2005)).  
Due to its beneficial effect in reducing side effects of commonly applied anti-cancer 
chemotherapy drugs like cisplatin (Baldew et al. 1989, Camargo et al. 2001, Markovic et al. 
2011), selenite (Na2SeO3) (Figure 7) is often applied as supplement in clinical trials (Dennert 
& Horneber 2006). Unfortunately, at high doses, selenite is cytotoxic itself to normal tissue (Li 
et al. 2007, Park et al. 2012a, Park et al. 2012b, Shen et al. 1999) and as mentioned before, 
the concentration range between beneficial and toxic effect is quite narrow. Therefore, the 
use of selenite in anti-cancer therapy is discussed controversially (Micke et al. 2009, Vinceti 
et al. 2001, Zhang et al. 2008b).  
Selenosulfate is proposed to replace selenite in anti-cancer-therapies (Zhang 2010).  
 
 
Figure 7: Structural formula of sodium selenite and selenosulfate. 
 
Selenosulfate was shown to be more cytotoxic to cancer cells compared to selenite (Zhang 
et al. 2008a). Experiments with mice exposed to cisplatin combined with either selenite or 
selenosulfate resulted in the same toxic effect on cancer cells, but healthy tissue was less 
damaged in the treatment with selenosulfate (Zhang et al. 2008b). In contrast to selenite, 
long-term administration (55 days) of selenosulfate in the same concentration did not result 
in toxic symptoms in mice (Li et al. 2012). Based on the results of the conducted cell 
experiments using the five different cell lines HepG2, Caco-2, and three different leukemia 
cell lines (HL60, T lymph adenoma, and Daudi), and experiments with mice, Zhang and co-
workers published a patent (Patent US 2010/0172822). This patent claims that selenosulfate 
is generally more toxic to cancer cells than selenite and therefore, selenite should be 
replaced by selenosulfate as supplement in anti-cancer chemotherapies. Study 3 of the 
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present thesis aims to reassess this general claim by comparing the cytotoxic effects of 
selenosulfate and selenite for three different cancer cell lines. 
 
 
1.4 Objectives 
The general aim of the present thesis was to further elucidate the influence of sulfur 
complexation on the cytotoxicity of the metalloids arsenic and selenium. 
When arsenic or selenium is present in sulfur-containing complexes, the toxicity of these 
metalloids is substantially influenced. This was already shown for methylated thioarsenicals 
compared to arsenite and arsenate and for selenosulfate compared to selenite. However, 
only few studies exist dealing with the cytotoxic potential of these compounds.  
For evaluating the toxic potential of thioarsenates, investigations about their bioavailability, 
e.g. their intestinal absorption, are crucial. Only few data exist about the intestinal transport 
of methylated thioarsenates and no data at all about the intestinal transport of inorganic 
thioarsenates. Study 1 of the present thesis therefore compares the intestinal transport of 
inorganic and methylated thioarsenates to the intestinal transport of arsenite and arsenate to 
further complete the concept of arsenic risk assessment after ingestion. 
No study at all exists about the toxicity of inorganic thioarsenates, although their formation 
during pre-systemic arsenic metabolism was proven and their existence has to be 
considered in terms of arsenic risk assessment after ingestion. Based on the lack of these 
data, study 2 of this thesis focusses on the toxicity of inorganic thioarsenates to human 
bladder and liver cells in comparison to arsenite and arsenate and links the modified 
toxicities to the cellular uptake of the different arsenic compounds.  
The reported increased toxicity of the selenium-sulfur compound selenosulfate compared to 
selenite to five different cancer cell lines was one crucial factor for the claim that 
selenosulfate is generally more potent in anti-cancer therapies than selenite. Study 3 of the 
present thesis aims for reassessing this general claim by comparing the toxicity of 
selenosulfate and selenite for three cancer cell lines. 
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2 METHODS 
2.1 Cell lines 
For testing the cytotoxicity of thioarsenates in comparison to arsenite and arsenate, two cell 
lines derived from target organs of arsenic toxicity were chosen: the human urothelial cell line 
UROtsa and the human hepatoma cell line HepG2. Just recently, several stocks of the 
UROtsa cell line turned out to be contaminated by another cell line and were identified as the 
human bladder cancer cell line T24 (Johnen et al. 2013). It is important to note that in study 2 
and in study 3 actually the same bladder cell line was used, even if it was designated as 
“UROtsa” in study 2 and as “T24” in study 3. 
As already described in section 1.2.3., the Caco-2 cell line serves as a model of the human 
small intestine and was therefore used in study 1 for comparing the intestinal transport of 
different arsenic species.  
In study 3, the cytotoxicity of selenosulfate and selenite were compared for three different 
cancer cell lines: HepG2, T24, and the melanoma cell line A375.  
The procedures of cell cultivation, cytotoxicity testing using the MTT assay, and cellular 
uptake of arsenic and selenium compounds are described in the respective studies. 
 
2.2 The Caco-2 model for quantifying intestinal transport of arsenic species 
The applied method for testing the bioavailability is described in detail in the Supporting 
Information of study 1 and is described only briefly at this point. 
For simulating the intestinal barrier, Caco-2 cells were seeded on filter inlets that were placed 
into a six-well-microtiterplate. The well below the filter represented the basal side (basement 
membrane) and the filter space above the Caco-2 cells represented the apical side (intestinal 
lumen). The Caco-2 cells were growing on the filter inlets for 21 days. Medium was changed 
three times a week. After this time, a confluent cell monolayer was built. The cell monolayer 
integrity was monitored during the 21 days of growing and before and during the arsenic 
incubation by measuring the transepithelial electrical resistance (TEER). Only TEER values > 
500 Ωcm² were assessed to present a stable and integer cell monolayer (Figure 8). 
For testing the intestinal transport of an arsenic species, the respective species was applied 
to the apical side and the basal medium was removed after 2, 4, 6, or 8 h for analysis of 
arsenic content and speciation. 
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Figure 8: Scheme of the Caco-2 model and measurement of the transepithelial electrical resistance 
(TEER). 
 
A method to quantify the paracellular transport of different arsenic species was applied in the 
context of study 1. However, the method failed and did not produce any reasonable results. 
The method is not considered in study 1 but is described in the following. 
The impact of a paracellular transport route (transport through the tight junctions) on the 
intestinal transport of the different arsenic species was investigated by reducing the Ca2+ and 
Mg2+ concentration in the cell growth medium and therefore leading to an opening of the tight 
junctions. 
For this purpose, the cell monolayer was pre-incubated for 5 minutes with a 5 mM EDTA 
solution (Applichem, Darmstadt, Germany, diluted in DPBS) just before the transport 
experiment according to a published method (Noach et al. 1993). The cell growth medium 
used in this experiment also contained 2.6 mM EDTA in order to complex excess Ca2+ and 
Mg2+ in the medium. 
To evaluate the effect of EDTA addition on the opening of the tight junctions, 100 µM of the 
fluorescent dye Lucifer Yellow was added to apical control wells in each experiment. Lucifer 
Yellow can only be transported via the paracellular route. After 2, 4, 6, and 8 h of 
incubations, basal aliquots of the Lucifer Yellow-treated wells were taken (50 µL) and 
fluorescence was measured (Tecan F200 Prro, excitation 485 nm, emission 535 nm).  The 
percentaged transport of Lucifer Yellow was quantified by setting cell medium containing 
100 µM Lucifer Yellow to 100 % and untreated cell medium to 0 %. Additionally, the influence 
of EDTA addition on the cell monolayer integrity was monitored by TEER measurements 
during each transport experiment. 
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2.3 Analysis of arsenic and selenium in cell medium and cell lysates 
Total content of arsenic and selenium in cell media and in cell lysates were analyzed by 
inductively coupled plasma – mass spectrometry (ICP-MS). The parameters are listed in the 
respective studies. 
Thioarsenates were determined by an AEC-ICP-MS method published before by Planer-
Friedrich et al. (2007). The parameters of this method are also described in studies 1 and 2. 
The same method was adapted for the analysis of selenite and selenosulfate (study 3). 
 
2.4 Speciation analysis of selenosulfate in cell growth medium 
For synthesizing the selenosulfate standard, selenite was mixed with glutathione and sulfide 
(detailed description of the selenosulfate synthesis is included in study 3). Before incubating 
the cells with the selenosulfate standard, each standard was diluted in ultrapure water and 
analyzed with AEC-ICP-MS to check the purity of the synthesized product and to detect 
unreacted selenite in the selenosulfate standard. 
The purity of the selenosulfate standard was determined as 91 ± 9.9 % and the selenosulfate 
peak was clearly discriminable from the selenite peak (Figure 9).  
 
 
Figure 9: AEC-ICP-MS chromatograms of selenosulfate and selenite analyzed after dilution in ultrapure 
water.  
 
To test whether selenosulfate was stable during the cell experiments, the media of 
selenosulfate experiments were analyzed for selenium species after the respective 
incubation times (24-72 h). Unfortunately, analysis of cell growth medium containing 
METHODS 
 
- 16 - 
 
selenosulfate did not result in reasonable peaks. Only when a chromatographic column had 
not been in contact with cell growth medium before, selenosulfate could be detected in one 
single sample (after 72 h incubation time). In subsequent samples, the selenosulfate peak 
disappeared and selenium eluted in the selenite peak only. Furthermore, the concentrations 
of the eluted selenium were far too low (about one third of the expected selenium 
concentration). Apparently, the cell growth medium changed the conditions of the stationary 
phase resulting in decreased elution of selenium compounds. As one single medium sample 
was sufficient to render the column useless for good separation of subsequent samples, 
frequent cleaning of the column was not sufficient to improve the method. 
Due to the low selenium concentrations in the toxicity experiments, the medium samples 
could not be diluted in ultrapure water to diminish these negative effects and therefore, the 
selenium speciation could not be analyzed in medium samples. 
Nevertheless, we derive sufficient stability of the selenosulfate standard for the duration of 
the cytotoxicity experiments from literature data (Zhang et al. 2008a), from no observed 
precipitation of  elemental selenium, and from the result that a selenosulfate peak was 
detected in one medium sample after 72 h of incubation. For this analysis, a 
chromatographic column was used that had not been in contact with cell growth medium 
before. 
    
 
- 17 - 
 
3 RESULTS AND DISCUSSION 
3.1 The influence of sulfur complexation on arsenic bioavailability and 
cytotoxicity 
3.1.1 The intestinal transport of thioarsenates compared to their non-thiolated 
analogues (Study 1, Hinrichsen et al. 2015) 
In this study, cellular retention and intestinal transport of two inorganic thioarsenates – MTAV 
and TTAV – and two methylated thioarsenates – MMMTAV and DMMTAV – were quantified 
using a Caco-2 cell monolayer model. To investigate the influence of thiolation, the intestinal 
transport of the thioarsenates was compared to that of the original present arsenic species 
after ingestion, e.g. arsenite/arsenate for all thioarsenates and additionally MMAV and DMAV 
for the methylated thioarsenates. Analyses of arsenic speciation were conducted in apical 
and basal media for each experiment to test whether the arsenic species were stable during 
the transport experiments.  
To test whether thioarsenates were transported via the transcellular (phosphate transporters) 
or the paracellular transport route, experiments were conducted in the complete absence of 
phosphate and in presence of EDTA, respectively. 
The different arsenic species considerably differed concerning their percentaged cellular 
retention in Caco-2 cells and concerning their passage through the Caco-2 cell monolayer. 
According to previous literature, arsenite was shown to be both retained in the cells and 
transported through the cell monolayer to a higher extent than all other arsenic species 
(Calatayud et al. 2011) and intestinal transport of arsenate, MMAV, and DMAV was negligibly 
low (Calatayud et al. 2010, Naranmandura et al. 2007a). Among the thiolated species, 
MMMTAV was the species of least concern, e.g. intestinal transport was only slightly higher 
compared to MMAV and cellular retention was even lower than that of MMAV. Comparing 
cellular retention and intestinal transport of DMMTAV and its non-thiolated analogue shows a 
substantially higher retention and transport for DMMTAV. Moreover, among all methylated 
arsenic compounds tested, cellular retention and intestinal transport of DMMTAV were by far 
the highest. 
In case of the inorganic thioarsenates, cellular uptake of MTAV was comparable to that of 
arsenate. The difference between these two species was that for MTAV, intestinal transport 
was more pronounced than cellular retention and for arsenate, intestinal transport was less 
pronounced than cellular retention. Cellular retention of TTAV was comparably low as that of 
arsenate, but very interestingly, intestinal transport of TTAV was the second highest of all 
tested arsenic species (only arsenite was higher). 
For all methylated and inorganic thioarsenates, transport experiments in complete absence 
of phosphate increased cellular retention by a factor of 2 to 6 indicating the involvement of 
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apical phosphate transporters for cellular uptake of thioarsenates. No results can be 
presented concerning the experiments to investigate the involvement of paracellular 
transport mechanisms by the addition of the Ca2+ and Mg2+-chelator EDTA. Unfortunately, 
pre-incubation with EDTA and addition of EDTA to the cell growth medium during the 
transport experiments considerably damaged the cell monolayer. This became obvious by 
monitoring the TEER values of the cell monolayers before and during the transport 
experiments. Before incubation, TEER values were > 500 Ωcm2 indicating a stable 
monolayer. But already after 1 h of EDTA-combined incubation with MTAV or TTAV, TEER 
values were < 200 Ωcm2 and even decreased further with time. In the absence of EDTA, the 
cell monolayer was not damaged by incubation with MTAV or TTAV alone in the same 
concentration (Figure 10). Percentaged transport of both Lucifer Yellow and MTAV and TTAV 
achieved values up to 50 % after 8 h of incubation (data not shown). That means that the 
apical arsenic-containing medium simply intermixed with the arsenic-free basal medium due 
to the concentration gradient as no barrier in form of an integer cell monolayer was present. 
 
 
Figure 10: Transepithelial electrical resistance (TEER) values during transport experiments (2-8 h). Cells 
were exposed to 10 µM MTAV or 10 µM TTAV, each in absence and presence of EDTA. Only TEER values 
> 500 Ωcm2 indicate cell monolayer integrity during arsenic exposure; treatments were conducted in 
triplicate; presented values are mean values ± standard deviation; control cells: cells in growth medium 
only; cells + EDTA: cells were treated with EDTA, but not with arsenic. TEER was also measured directly 
before arsenic incubation (t = 0 h) to ensure cell monolayers were intact before the transport experiment. 
500 Ω cm2 
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In transport experiments with individually applied MTAV, TTAV, and arsenate, arsenic 
speciation analyses of the basal media showed that the inorganic thioarsenates and 
arsenate were transported intact through the cell monolayer. As also arsenite was present in 
the basal media in considerable amount, intracellular reduction of the thioarsenates to some 
extent cannot be completely excluded.  
No results about the arsenic speciation during the transport experiments with methylated 
thioarsenates can be presented because their basal concentrations were too low for 
identifying these species. Additionally, matrix interferences with components from the cell 
growth medium led to chromatographic problems in this case. However, based on data from 
previous studies (Leffers et al. 2013b), methylated thioarsenates are assumed to be 
transported intact through the Caco-2 cell monolayer. 
The present study could show that thiolation definitely has a strong effect on the transport 
behavior of arsenic compounds. Still, for a general evaluation whether thiolation increases or 
decreases the bioavailability of the original present arsenic substrate, more research is 
needed to elucidate the exact mechanisms of thioarsenate formation. More precisely, it is not 
fully understood, yet, if thioarsenates are formed from their pentavalent analogues (arsenate 
for inorganic thioarsenates, MMAV for MMMTAV, and DMAV for DMMTAV) or from trivalent 
arsenic species with arsenite being the original present species. If thioarsenates are formed 
from their structural pentavalent analogues, thiolation increases intestinal transport of 
arsenic, but if they are formed from trivalent species, thiolation decreases intestinal transport 
of arsenic, whereas trithioarsenate presents an exception because it is almost as 
bioavailable as arsenite. 
Previous studies showed that DMMTAV is considerably more cytotoxic than its non-thiolated 
structural analogue DMAV (Leffers et al. 2013a, Naranmandura et al. 2011, Raml et al. 2007). 
Therefore, DMMTAV is an arsenic species of special concern during pre-systemic arsenic 
metabolism due to both increased bioavailability and toxicity.  
Inorganic thioarsenates are more bioavailable than arsenate but lower bioavailable than 
arsenite. To further investigate their toxic potential compared to arsenite and arsenate, study 
2 of the present thesis focusses on the cytotoxicity of MTAV and TTAV in comparison to 
arsenite and arsenate and links the cytotoxicity of the different arsenic compounds to cellular 
retention.
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3.1.2 The cytotoxicity of inorganic thioarsenates compared to arsenite and 
arsenate (Study 2, Hinrichsen et al. 2014) 
In this study, the cytotoxicity of inorganic thioarsenates was compared with that of arsenite 
and arsenate for human hepatocytes (HepG2) and urothelial cells (UROtsa) using the MTT 
assay. For this purpose, sulfide was added to an arsenite solution in cell growth medium 
(molar As/S ratio of 1:4) and the cytotoxic effects – e.g. the decrease of cell viabilities – of 
arsenite alone and the arsenite-sulfide-mixture were compared after 6 and 24 h of 
incubation. Thioarsenates formed in the arsenite-sulfide solutions were quantified by AEC-
ICP-MS analyses. To evaluate the cytotoxicity of individual thioarsenates, synthesized 
standard solutions of MTAV and TTAV were compared to arsenite and arsenate. To assess 
whether simply cellular uptake determines the cytotoxicity of the respective arsenic species, 
cellular uptake was determined for MTAV, TTAV, arsenite, and arsenate and compared to the 
order of cytotoxicity. 
For both HepG2 and UROtsa cells, the cytotoxicity of arsenite was reduced by addition of 
sulfide after 6 h of incubation and for HepG2 additionally after 24 h of incubation. For 
UROtsa cells, cell viabilities did not significantly differ after 24 h between the arsenite-sulfide 
treatment and the exclusive arsenite treatment. Speciation analyses showed the immediate 
formation of inorganic thioarsenates (36-73 % of total arsenic, dominant species was TTAV) 
in the cell growth media of both cell lines that were treated with arsenite and sulfide. In 
general, UROtsa cells showed higher susceptibility to arsenic exposure than HepG2 cells. 
With time, the thioarsenates converted into arsenite in the cell growth medium and after 24 h, 
only 33 % of total arsenic was present as thioarsenates in cell growth medium. The general 
higher susceptibility of UROtsa cells towards arsenite exposure implies a faster reaction to 
arsenite exposure compared to HepG2 cells and thus explains the marginal influence of 
sulfide on arsenite cytotoxicity for UROtsa cells after 24 h as a substantial percentage of the 
formed thioarsenates converted to arsenite after 24 h. 
The decreased cytotoxicity of arsenite in presence of sulfide could be traced back to the 
formation of inorganic thioarsenates, as cytotoxicity experiments with standard solutions of 
arsenite, arsenate, MTAV, and TTAV standards showed for both cell lines and both incubation 
times the following order of cytotoxicity: arsenite > TTAV > MTAV > arsenate. It is in 
accordance to previous literature that arsenite is considerably more cytotoxic than arsenate 
(Dopp et al. 2008, Styblo et al. 2000).  
The order of cellular arsenic uptake after 24 h of incubation was determined for HepG2 cells 
as arsenite > TTAV > MTAV > arsenate and for UROtsa cells as arsenite ≈ TTAV > MTAV > 
arsenate. The lower uptake of arsenate compared to arsenite can be explained by different 
uptake mechanisms. Arsenite is taken up by cells via aquaglyceroporins or diffusion, 
arsenate is taken up by inorganic phosphate transporters and therefore, arsenate uptake can 
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be inhibited by the presence of phosphate. In the conducted experiments, phosphate was 
both present in the used cell growth medium and in the buffer solution used for washing the 
UROtsa and the HepG2 cells. Therefore, arsenate uptake was likely reduced by the 
presence of phosphate. 
No studies exist about the uptake mechanisms of thioarsenates. Based solely on the charge 
of MTAV, its uptake mechanism should be similar to that of arsenate. 
As the order of cellular uptake corresponded in general to the order of cytotoxicity for both 
cell lines, cellular arsenic uptake can be seen as crucial for the cytotoxic potential of different 
arsenic species.  
Combining the results of study 1 and study 2 of the present thesis, thioarsenates possess 
both lower bioavailability and cytotoxicity compared to arsenite and both higher bioavailability 
and cytotoxicity compared to arsenate. Regarding arsenite as precursor of thioarsenate 
formation, thiolation presents a detoxification process. However, in comparison to arsenate 
as the structural analogue of thioarsenates and a potential precursor (if gut microorganisms 
can directly thiolate pentavalent species), thiolation presents an activation process. More 
research is needed about the exact formation mechanisms of thioarsenates for a better 
interpretation of the influence of thiolation on the cytotoxic potential of arsenic.  
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3.2 Comparing the cytotoxicity of selenite and the selenium-sulfur compound 
selenosulfate (Study 3, Hinrichsen & Planer-Friedrich submitted) 
In this study, the cytotoxic effects of selenite and the selenium-sulfur-compound 
selenosulfate were quantified and compared by means of the MTT assay for the three 
different cancer cell lines HepG2 (human hepatocytes), A375 (malignant melanoma cells), 
and T24 (urinary bladder carcinoma cells) with the objective of verifying the general claim 
that selenosulfate is more cytotoxic than selenite for cancer cells (Zhang 2010). The IC50 
values (inhibitory concentration of selenosulfate or selenite inducing 50 % cell viability) were 
calculated. Cellular uptake of the two selenium compounds was quantified to investigate the 
relation between the uptake and the cytotoxicity of selenosulfate and selenite, respectively. 
The cytotoxicity of selenosulfate was similar among the three different cell lines (IC50 6.6-
7.1 µM), but the cytotoxicity of selenite was considerably different. The order of susceptibility 
towards selenite exposure among the three cell lines was T24 > A375 > HepG2 (IC50 values 
3.5, 5.7, 15 µM). 
Only HepG2 cells – the cells that were already used in the experiments from Zhang and co-
workers (Zhang et al. 2008a) – showed the expected result that selenosulfate was 
significantly more cytotoxic than selenite after 24 h of incubation (difference in cell viabilities 
up to 50 %). For A375 cells, incubation with selenosulfate and selenite resulted in 
comparable cell viabilities and in case of T24 cells, selenosulfate was even less cytotoxic 
than selenite (difference in cell viabilities up to 45 %). Based on the fact that only one of 
three investigated cancer cell lines showed results that are consistent with the patent of 
Zhang and co-workers (Zhang 2010) one has to challenge the general conclusion of the 
patent that selenosulfate should replace selenite as supplement in anti-cancer-therapies.  
Intracellular selenium concentration after 24 h incubation with 1.7 µM selenosulfate and 1 µM 
selenite, respectively, could be quantified in HepG2 and T24 cells. For HepG2 cells, the 
higher cytotoxicity of selenosulfate compared to selenite was in accordance with higher 
intracellular selenium concentrations after selenosulfate incubation and for T24 cells, the 
lower cytotoxicity of selenosulfate compared to selenite was in accordance to lower 
intracellular selenium concentrations after selenosulfate incubation.  
Although the cytotoxicity of selenosulfate and selenite in A375 was comparable to HepG2 
and T24 cells, selenium concentrations in A375 cells were not distinguishable from non-
exposed control cells after exposure to 1.7 µM selenosulfate and 1 µM selenite, respectively. 
A potential reason could be that A375 cells were cultivated in a different growth medium 
(Dulbecco’s modified Eagle Medium, DMEM) than HepG2 and T24 which were cultivated in 
minimum essential medium (MEM). The DMEM medium contained twice as much L-cystine 
compared to the MEM medium. The extracellular cystine likely reduced the presence of 
reduced glutathione (GSH) resulting in a decreased defense against oxidative stress 
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produced by selenium. By this, remarkable toxic effects in the A375 cells occurred even at 
extremely low selenium uptake. 
For the 24 h experiments, HepG2 cells were routinely cultivated in non-essential amino acids 
(NEAA)-containing MEM and T24 cells in NEAA-free MEM. To further investigate the 
observed effect of selenosulfate and selenite cytotoxicity, experiments were conducted with 
HepG2 and T24 cells in the presence and absence of NEAA as medium supplement for 
three different exposure times (24, 48, and 72 h). 
The cytotoxicity of selenosulfate was largely independent of exposure time, cell line, and 
presence or absence of NEAA. For HepG2 cells, selenosulfate was under all applied 
conditions more toxic than selenite, but the effect diminished with time due to a strong 
increase of selenite cytotoxicity with time. The large difference between selenosulfate and 
selenite cytotoxicity for HepG2 cells seemed to be a short-time. The relatively low selenite 
cytotoxicity for HepG2 cells after 24 h can be traced back to low selenite uptake. The 
presence of NEAA slightly decreased the cytotoxicity of selenosulfate and selenite only for 
longer incubation times. 
In contrast, the addition of NEAA in the cytotoxicity experiments with T24 had a remarkable 
effect concerning the cytotoxicity of selenite: Presence of NEAA down-regulated selenite 
uptake leading to a significantly reduced selenite cytotoxicity. After 24 h, selenosulfate was 
even more toxic than selenite for T24 cells – just as observed for the HepG2 cells. At longer 
incubation times, cell viability curves for selenosulfate and selenite exposed T24 cells 
assimilated as already observed for HepG2 cells. 
The strong effect of NEAA presence on T24 cells – a reversion of selenosulfate and selenite 
cytotoxicity - could be explained by an effect on the cellular cysteine/glutamate exchange 
system xc- which is essential for the cellular selenite uptake. This transport system regulates 
the extracellular reductive environment by secretion of cysteine which subsequently reduces 
selenium compounds. Reduced selenium species are known to be preferentially transported 
into cells (Conrad & Sato 2012).  
The amino acid L-glutamic acid (one component in the applied NEAA mixture) is known to 
inhibit the xc- transport system resulting in decreased selenite uptake and cytotoxicity (Olm et 
al. 2009). The xc- transport system was shown to be more present in selenite-sensitive cells 
compared to selenite-resistent cells (Wallenberg et al. 2014) which let us conclude that it is 
also more expressed in T24 compared to HepG2 cells. This explains why the cytotoxicity of 
selenite is significantly affected by presence of NEAA in T24 cells. 
The results of this study show that for evaluating the cytotoxic effects of selenosulfate and 
selenite for a specific cell line, one has to consider the sensitivity of the specific cell line and 
the composition of cell growth medium which might influence the reductive state of the 
extracellular environment and therefore the uptake and cytotoxicity of selenium.
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4 CONCLUSION 
The results of the three presented studies definitely show that cellular uptake and cytotoxicity 
of the metalloids arsenic and selenium change when they are sulfur-complexed.  
Although formation of thioarsenates during pre-systemic arsenic metabolism had been 
proven before, hardly any data existed about their intestinal transport and toxicity until the 
publication of study 1 and 2 of the present thesis. These studies include the very first 
published data about the intestinal transport and cytotoxicity of inorganic thioarsenates. For 
methylated thioarsenates, only some data existed about their intestinal transport and their 
cytotoxicity and these data are considerably supplemented by the data of study 2. 
Further studies are important to investigate the bioavailability and toxicity of thioarsenates, 
focusing on the precise mechanisms of transport and toxicity. For this purpose, a method for 
synthesizing a dithioarsenate standard is required to link the degree of thiolation (e.g. 
number of SH- groups) to bioavailability and toxicity of the thioarsenates. 
Furthermore, detailed research on the exact formation mechanisms of thioarsenates is 
essential for a reliable interpretation of thiolation being a process of reduced bioavailability 
and detoxification or increased bioavailability and activation in comparison to the originally 
present trivalent or pentavalent arsenic substrate. 
Study 3 showed that cellular uptake and cytotoxicity of selenite is modulated by the presence 
of amino acids in the cell growth medium to such an extent that selenosulfate can possess 
higher (presence of amino acids) or lower (absence of amino acids) cytotoxicity compared to 
selenite in bladder cancer cells. The general claim that selenosulfate is more cytotoxic than 
selenite and should therefore preferentially be used in anti-cancer therapies therefore has to 
be rejected. For evaluating a possible role of selenosulfate in anti-cancer therapies, more 
toxicity studies under strictly defined conditions on the basis of different model organisms are 
indispensable. Again, further studies are required to elucidate the mechanisms of cellular 
uptake and toxicity of selenium and selenium-sulfur compounds. 
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ABSTRACT: Arsenic forms diﬀerent species that are toxic for humans.
Toxicity to internal organs is, however, only relevant if the respective species
passes the gastrointestinal barrier. Thioarsenates were known to be
produced by gut microbiota and to be toxic to bladder and liver cells, but
their intestinal transport was largely unknown. Using a Caco-2 cell model,
we show here that dimethylmonothioarsenate has the highest cellular
retention and intestinal transport of all methylated species. Mono- and
trithioarsenate show little cellular retention like arsenate, but their intestinal
transport is much higher than that of arsenate; for trithioarsenate, it is
almost as high as that for arsenite. The transport of all thioarsenates
increases in the absence of phosphate. With the present study, we link
previous reports of thioarsenate formation and toxicity by proving their
bioavailability and conﬁrm the relevance of their consideration in As risk
assessments.
A rsenic (As) is a known carcinogen. Taken up mainly asarsenate, e.g., in drinking water or food, ingested As
undergoes speciation changes which determine its bioavail-
ability, systemic distribution, and toxicity. Commonly known
metabolisms before absorption across the gastrointestinal
barrier are reduction to arsenite or methylation. Thiolation
(replacement of OH− versus SH− groups) is much less
investigated, even though the prevalence of H2S-producing
organisms in gut microbiota and the high pH of the distal
gastrointestinal tract favor thiolation. It is known that gut
microbiota produce inorganic and methylated thioarsenates.1−3
Espec ia l ly d imethy lmonothioarsenate (DMMTAV ,
(CH3)2As
VOS−) is a common metabolite in human urine,
formed by thiolation of dimethylarsenate (DMAV ,
(CH3)2As
VO2
−).1 For hepatocytes, DMMTAV is 10 times
more toxic than DMAV.4 For urothelial cells, it is 100 times
more toxic than DMAV and 4 times more toxic than arsenite.5,6
Inorganic thioarsenates are less toxic than arsenite but more
toxic than arsenate for human hepatocytes and urothelial cells.7
The missing link to evaluate the relevance of thiolation for
human toxicity is the information whether and to what extent
thioarsenates can pass the gastrointestinal barrier; tri- and
pentavalent inorganic and methylated As species have been
studied before; among the thiolated species, only DMMTAV
has been studied.8−10 Here, we examined cellular retention and
intestinal transport, speciation changes, and the importance of
phosphate transporters on a Caco-2 cell monolayer model for
the eight diﬀerent As species: monothioarsenate (MTAV,
AsVO3S
3−), trithioarsenate (TTAV, AsVOS3
3−), monomethyl-
monothioarsenate (MMMTAV, (CH3)As
VO2S
2−), and
DMMTAV, in comparison to arsenate, arsenite, monomethyl-
arsenate (MMAV, (CH3)As
VO3
2−), and DMAV. Supporting
Information summarizes descriptions of cell culture, transport
experiments, synthesis, and analysis of As species.
Total As analyses showed that cellular retention and passage
through the cell monolayer varied among the tested inorganic
or methylated, thiolated, or nonthiolated species (Figure 1). In
accordance with previous literature, intestinal transport of
arsenite clearly exceeded that of all other As species (Figure
1a,c).9 Cellular As retention after arsenite exposure (Figure 1b)
was higher than that after exposure to arsenate (reported
before),11 MMAV, and DMAV. Intestinal transport of arsenate
(Figure 1a,c), MMAV, and DMAV (Figure 1d,f) was negligible
as observed before.8,12 Regarding the thiolated species,
MMMTAV was the species of least concern. Its intestinal
transport was only slightly higher than that of its nonthiolated
and less toxic original substrate MMAV (Figure 1f), and cellular
retention was even lower (Figure 1e).6,11 For DMMTAV,
cellular retention (Figure 1e) and intestinal transport (Figure
1f) clearly exceeded those of the less toxic DMAV and all other
methylated As species. For inorganic thioarsenates, cellular
uptake of MTAV was comparable to that of arsenate (Figure
1a), but cellular retention was lower (Figure 1b) inducing
higher intestinal transport of MTAV (Figure 1c). Cellular
retention of TTAV was as low as that of arsenate (Figure 1b),
but intestinal transport was the second highest among all tested
As species (Figure 1c), and at 10 μM As incubation, it was even
comparable to that of arsenite (Figure S2). In the absence of
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phosphate, cellular retention increased for all thioarsenates by a
factor 2 to 6 (Table S1 and Figure S3), implying the
importance of apical phosphate transporters for all thiolated
species. Increased basal concentrations were only observed for
the methylthiolated species (Figure S3).
Speciation analyses of As in the basal compartment
conﬁrmed that MTAV and TTAV were transported intact
through the intestinal cells. It is not possible to answer whether
this transport is quantitative, i.e., without any intracellular
species transformation. Comparing relative species distributions
between the apical and basal compartments, a higher share of
arsenite was observed in the basal compartment (Figures S4
and S5, also for arsenate Figure S6). This could indicate that
arsenate and thioarsenates were reduced intracellularly.
However, all inorganic pentavalent standards contained arsenite
in the applied apical solution either as small impurities in a
commercial standard (<1.5% arsenite in arsenate) or as
nonreacted remainders of synthesis (8% arsenite in MTAV
and 40−50% in TTAV; see Supporting Information). Absolute
concentrations of arsenite in the basal compartment were so
low that the arsenite impurity in the apical compartment would
be suﬃcient to explain the arsenite presence in the basal
compartment, simply assuming preferred transport of arsenite
over thioarsenates (Table S2). The thiomethylated standards
contained no arsenite in the apical solution. Basal concen-
trations in our study were too low for identifying species above
matrix interferences (see Supporting Information). However, at
least DMMTAV has already been detected in the basal
compartment before.10 The fact that thioarsenates survive
gastrointestinal transport supports the need for evaluating their
systemic distribution and toxicity to diﬀerent organs as has
been started before.5,7 In addition, the intestinal transport of all
tested As species might even be underestimated due to the
strong tight junctions of Caco-2 cells compared to that of real
cells of the small intestine.13
For a general evaluation on whether intestinal thiolation
increases or decreases As bioavailability and toxicity, it is
important to know the formation pathway of thioarsenates. If
they form from their pentavalent structural analogues (arsenate
for inorganic thioarsenates, MMAV for MMMTAV, and DMAV
for DMMTAV), thiolation increases both intestinal transport
(results from this study) and toxicity.4,5,7 Some studies with
mouse cecum microbiota seem to support direct thiolation of
pentavalent species; no prereduction to arsenite was observed.2
In contrast, previous abiotic studies showed that direct
thiolation of inorganic and organic pentavalent As species
only occurred at pH < 4, while at neutral pH, like in the human
intestinal tract, thiolation of inorganic arsenates proceeded via
trivalent As species.14,15 This pathway is in line with observed
presystemic microbial reduction of arsenate before thiolation
and the suggestion that DMAV reduction to DMAIII facilitates
thiolation.1,3 If reduced species are the original substrates for
thioarsenates, thiolation means an overall decrease in toxicity.
More studies are therefore required to elucidate intestinal
formation mechanisms.
In summary, our study provides the link between previous
reports on intestinal formation of thioarsenates and their
toxicity by showing that inorganic and methylated thioarsenates
can pass the gastrointestinal barrier. Compared to their
pentavalent structural analogues, thioarsenates are more
Figure 1. Total arsenic concentrations in apical (a,d), intracellular (b,e), and basal (c,f) compartments after individual exposure to inorganic and
organic arsenic species. For better comparison, arsenic is presented in percent distribution between the three compartments for each species and
corrected for the number of cells used in each experiment; Table S1 includes all individual values.
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bioavailable and more toxic. Considering that thioarsenates
likely form from arsenite, thiolation is a detoxiﬁcation
metabolism. Trithioarsenate is an exception; it is almost as
bioavailable and toxic as arsenite.
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Materials and Methods 
Transport through the Caco-2 monolayer was investigated and compared for the four different 
inorganic arsenic and arsenic-sulfur species arsenite, arsenate, monothioarsenate (MTAV), and 
trithioarsenate (TTAV), for the methylated As species monomethylarsenate (MMAV) and 
dimethylarsenate (DMAV) and for the thiomethylated As species monomethylmonothioarsenate 
(MMMTAV) and dimethylmonothioarsenate (DMMTAV). Transport of MTAV, TTAV, MMAV, 
DMAV, MMMTAV, and DMMTAV was also investigated in complete absence of phosphate during the 
transport experiment.  
Cell cultures  
The Caco-2 cell line was purchased from DSMZ (German Collection of Microorganisms and Cell 
Cultures, Braunschweig, Germany). Cells were cultivated in minimum essential medium with Earle’s 
Salts (MEM, c·c·pro, Oberdorla, Germany) supplemented with 10% Fetal Bovine Serum (FBS, Gibco, 
Karlsruhe, Germany), 0.5% gentamycine, 1% L-glutamine, 1% 1M HEPES, and 1% Amphotericin B 
(all c·c·pro, Oberdorla, Germany) and incubated in a humidified atmosphere at 37 °C and 5% CO2 
(Incubator Galaxy 170 S, New Brunswick Scientific). Cells were passaged three times weekly using 
0.25% trypsin-EDTA (c·c·pro, Oberdorla, Germany).  
Reagents and synthesis of thioarsenate standards 
All reagents used were of the highest purity available, of at least analytical-reagent grade, and they 
were sterile-filtered before cell exposure. Sodium(meta)arsenite (AsNaO2), sodium arsenate dibasic 
heptahydrate (AsHNa2O4 ·  7 H2O), and sodium cacodylate trihydrate (C2H6AsNaO2, DMAV) were 
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purchased from Sigma-Aldrich (Steinheim, Germany). Disodium methyl arsonate hexahydrate 
(CH3AsNa2O3 ·  6 H2O, MMAV) was purchased from Chem Service, West Chester, Pennsylvania.  
MTAV (Na3AsO3S ·  7 H2O) and tetrathioarsenate (TetraTAV, Na3AsS4 ·  8 H2O) were synthesized 
based on a modification of previously published procedures with the exception that commercial 
arsenic pentasulfide (As2S5, Santa Cruz Biotechnology, Inc, Heidelberg, Germany) was used instead of 
self-synthesized material for TetraTAV synthesis.1, 2 Based on speciation analysis by anion exchange 
chromatography coupled to an inductively coupled plasma mass spectrometry (AEC-ICP-MS), 
dissolving the synthesized MTAV crystals in autoclaved water (Ampuwa; Fresenius Kabi, Bad 
Homburg, Germany) yielded more than 98% MTAV. The purity of TetraTAV was greater than 90% 
when dissolved in 0.1 M NaOH and re-analyzed by AEC-ICP-MS. Dissolving TetraTAV in Ampuwa 
yielded more than 60% TTAV (rest was mainly unreacted arsenite) due to the pH instability of 
TetraTAV.3 Consequently, in the experiments, cells were principally exposed to TTAV as the 
TetraTAV standard was diluted in Ampuwa to ensure physiological pH.  
MMMTAV and DMMTAV were synthesized under N2/H2 - atmosphere (Glovebox, Coy) based on a 
published procedure 4: MMAV (for MMMTAV synthesis) or DMAV (for DMMTAV synthesis) were 
mixed with sodium sulfide (Na2S ·  9 H2O) in a molar S:As ratio of 10. The pH value was adjusted to 3 
by adding 0.1 M HCl. After a reaction time of 30 min, the pH value was increased to 12.3 by adding 
1 M NaOH. In case of MMMTAV synthesis, almost complete thiolation of MMAV was observed 
immediately after the reaction time. MMMTAV was synthesized one hour before the respective 
experiment. In case of DMMTAV synthesis, thiolation was slower. The standard was left for 7-10 days 
in the refrigerator to yield a maximum percentage of DMMTAV (50%; rest was unreacted DMAV). 
 
Transport of arsenic species through Caco-2 monolayer in apical-basal direction  
A total of 7.5·104 cells in 2 mL growth medium (apical side) were seeded in 6-well Millicell®
 
Hanging 
Cell Culture Inserts (Millipore, Schwalbach, Germany). The inserts were placed into 6-well plates 
(Omnilab, Munich, Germany) which contained 4.2 mL fresh growth medium (basal side). Medium 
was changed three times weekly followed by measurement of the transepithelial electrical resistance 
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(TEER) using the Millicell ERS-2 (Electrical Resistance System, Millipore, Schwalbach, Germany) to 
control the growing confluence of the Caco-2 monolayer. Transport experiments were conducted 21 
days after seeding. Only cell layers with TEER values > 500 Ωcm2 were used for the experiments as 
this value was assessed to indicate complete cell monolayer integrity. TEER values were measured 
immediately before starting the transport experiments and they were also monitored during the 
duration of incubation to ensure that cell monolayers were not damaged by As exposure (Figure S1). 
During the transport experiments, both apical and basal compartment contained 2 mL growth medium. 
Arsenic stock solutions were prepared in autoclaved water and were 100-fold diluted in growth 
medium for incubation resulting in final As concentrations of 1 and 10 µM for arsenite, arsenate, 
MTAV, TTAV and 2.7 µM for MMAV, DMAV, MMMTAV, and DMMTAV. Each treatment was 
conducted in triplicate. Sampling of medium was conducted after 2, 4, 6, and 8 h of incubation. 
Medium was removed from the apical and basal compartment, was flash-frozen and stored in liquid 
nitrogen until analysis of As speciation and total As content. 
Arsenic retention during transport experiments 
After the removal of apical and basal medium, the apical and the basal side of the cell monolayer each 
were washed twice with Dulbecco’s Phosphate Buffered Saline (DPBS, Gibco, Karlsruhe, Germany) 
to remove remaining As. The cells were trypsinized, resuspended in DPBS, counted (CASY Model 
TT, Roche Applied Sciences), and mechanically lysed using glass beads (Retsch GmbH, Germany).  
Transport experiments in the absence of phosphate 
To test whether the transport of MTAV, TTAV, MMAV, DMAV, MMMTAV, and DMMTAV competes 
with the uptake of phosphate, transport experiments in the absence of phosphate were conducted. The 
As concentration added to the apical compartment was 10 µM for MTAV and TTAV and 2.7 µM for 
MMAV, DMAV, MMMTAV, and DMMTAV. For all experiments, phosphate-free MEM was used 
(c·c·pro, Oberdorla, Germany) and sodium dihydrogen phosphate dihydrate (Sigma-Aldrich, 
Steinheim, Germany) was added resulting in 10% of standard phosphate concentration. To let the cells 
adapt to reduced phosphate availability, they were at least passaged three times in phosphate-reduced 
growth medium before seeding them into the filter inlets. During the 21 day-postseeding time, cells 
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were also cultivated in phosphate-reduced growth medium. Morphology and amount of cells during 
cultivation in phosphate-reduced growth medium were not affected. For the transport experiment, 
phosphate-free growth medium was applied in both apical and basal compartment and sampling 
procedure corresponded to the experiments in standard growth medium with the exception that 
Ampuwa was used for rinsing the cell layer instead of DPBS.   
Analysis of total As content 
To quantify As cellular retention and transport in the apical-basal direction, total As concentrations of 
cell lysates, apical and basal medium were determined by ICP-MS (XSeries2, Thermo-Fisher). In case 
of As quantification in cell lysates, the results were corrected by an internal rhodium standard 
(rhodium standard in 5 % HCl, 1000 ppm, Ultra Scientific Analytical Solutions, No. Kingstown, RI, 
USA) to compensate for changes in sensitivity. Final rhodium concentration in each sample was 
5 ppb. For better comparability, the percentage As concentrations in apical, intracellular, and basal 
compartments were always referred to a total of 106 cells. 
Analysis of As speciation in apical and basal medium 
To evaluate the stability of the As species used in the growth medium during the transport experiments 
and to identify changes of speciation during their transport through the Caco-2 monolayer, As species 
were analyzed using anion exchange chromatography (Dionex 3000) coupled to the ICP-MS (AEC-
ICP-MS). For the analysis of inorganic As species, an anion suppressor was used before introducing 
the samples into the ICP-MS to reduce the salt load in the solutions. For the methylated As species no 
suppressor could be used because it also exchanges DMAV. The instrument parameters for the 
separation of inorganic As species (Table S3) and methylated As species (Table S4) are listed below. 
Arsenic was determined as AsO+ (m/z = 91) using the dynamic reaction cell (DRC) with O2 as 
reaction gas as described before.5 Arsenite and arsenate were quantified using standard solutions of the 
respective solid. Inorganic thioarsenates were quantified on the basis of the arsenate calibration curve. 
The validity of this approach was shown in a previous publication.5  
The methylated thioarsenic species MMMTAV and DMMTAV could be separated nicely by 
chromatography when the standards were diluted in ultrapure water (Figure S7). When analyzing these 
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thiomethylated species in cell growth medium some chromatographic problems were encountered and, 
unfortunately, total As concentrations were too low to solve these matrix interferences completely by 
sufficient dilution in ultrapure water. In the apical solutions, the following problems occurred: For 
MMMTAV, the MMAV peak was not baseline-separated from MMMTAV and some As eluted in the 
dead volume (Figure S7 B). However, a significant transformation of MMMTAV to MMAV would 
have been distinguishable and did not occur. We could also exclude transformation into arsenate or 
arsenite. In case of DMMTAV, matrix interference in cell growth medium led to elution of both DMAV 
and DMMTAV in the column’s dead volume (Figure S7 C). We could thus not exclude transformation 
of DMMTAV into DMAV, but we could exclude transformation into arsenite or arsenate, and 
significant amounts of MMMTAV and MMAV. For the basal solutions, totals As concentrations were 
too low to yield good peaks above these matrix interferences. So, no speciation results are available 
for the basal solutions of the MMMTAV and DMMTAV experiments.
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T a b l e  1 :  P e r c e n t a g e  a r s e n i c  d i s t r i b u t i o n  i n  a p i c a l ,  i n t r a c e l l u l a r ,  a n d  b a s a l  c o m p a r t m e n t  [ %  A s / 1 0
6
 c e l l s ]  a f t e r  i n c u b a t i o n  w i t h  t h e  d i f f e r e n t  A s  s p e c i e s ;    - * :  s a m p l e  w a s  u s e d  f o r  
A s  s p e c i a t i o n  a n a l y s i s ;  - * * :  l o s t  s a m p l e ;  m e a n  v a l u e s  a n d  s t a n d a r d  d e v i a t i o n s  w e r e  d e t e r m i n e d  i n  c a s e  t h r e e  s a m p l e s  f o r  t o t a l  a r s e n i c  a n a l y s i s  w e r e  a v a i l a b l e .
 
  
2  h 4  h 6  h 8  h 2  h 4  h 6  h 8  h 2  h 4  h 6  h 8  h 2  h 4  h 6  h 8  h
a p i c a l  8 5 . 8 7 9 . 5 7 2 . 9 6 4 . 2 9 5 . 6 9 6 . 5 9 6 . 8 9 3 . 8 9 5 . 1 - * - * - * 9 3 . 3 8 6 . 4 8 2 . 8 7 6 . 7
8 1 . 1 7 9 . 8 7 6 . 7 6 0 . 2 9 6 . 6 9 6 . 5 9 6 . 6 9 5 . 2 9 6 . 6 9 5 . 8 9 1 . 8 9 1 . 8 9 2 . 6 8 5 . 7 8 1 . 7 7 9 . 1
- * - * - * - * 9 5 . 2 9 5 . 7 - * 9 3 . 8 9 6 . 4 9 5 . 8 9 3 . 8 - * 9 4 . 8 8 8 . 2 8 2 . 9 7 6 . 3
m e a n 9 5 . 8 9 6 . 3 9 6 . 0 9 3 . 5 8 6 . 8 8 2 . 5 7 7 . 4
S D 0 . 7 0 . 5 0 . 8 1 . 1 1 . 3 0 . 7 1 . 5
i n t r a c e l l u l a r 3 . 4 3 . 9 5 . 6 6 . 4 1 . 6 1 . 7 1 . 5 4 . 4 0 . 8 0 . 9 1 . 1 - * 1 . 3 2 . 1 2 . 3 2 . 5
3 . 5 4 . 0 3 . 8 6 . 2 1 . 6 1 . 7 1 . 5 1 . 7 0 . 8 0 . 9 1 . 3 1 . 6 1 . 6 2 . 2 2 . 3 2 . 7
4 . 8 4 . 6 4 . 3 7 . 0 3 . 2 1 . 9 2 . 1 1 . 8 0 . 8 0 . 9 1 . 2 1 . 6 1 . 3 2 . 2 2 . 3 2 . 6
m e a n 3 . 9 4 . 2 4 . 6 6 . 5 2 . 1 1 . 8 1 . 7 2 . 6 0 . 8 0 . 9 1 . 2 1 . 4 2 . 2 2 . 3 2 . 6
S D 0 . 8 0 . 3 0 . 9 0 . 4 0 . 9 0 . 1 0 . 3 1 . 6 0 . 0 0 . 0 0 . 1 0 . 1 0 . 1 0 . 0 0 . 1
b a s a l 1 0 . 8 1 6 . 6 2 1 . 5 2 9 . 5 2 . 8 1 . 8 1 . 7 7 . 5 4 . 1 - * - * 7 . 1 5 . 4 1 1 . 5 1 4 . 9 2 0 . 8
1 5 . 4 1 6 . 1 1 9 . 5 3 3 . 5 1 . 8 1 . 8 2 . 0 3 . 1 2 . 6 3 . 3 6 . 9 6 . 6 5 . 9 1 2 . 1 1 6 . 0 1 8 . 1
- * - * - * - * 1 . 6 2 . 3 - * 4 . 4 2 . 8 3 . 3 5 . 0 - * 3 . 9 9 . 6 1 4 . 8 2 1 . 1
m e a n 2 . 1 2 . 0 5 . 0 3 . 2 5 . 1 1 1 . 1 1 5 . 2 2 0 . 0
S D 0 . 6 0 . 3 2 . 3 0 . 8 1 . 0 1 . 3 0 . 7 1 . 6
a r s e n i t e a r s e n a t e M T A
V
T T A
V
 a l l  v a l u e s  p r e s e n t e d  i n  % A s / 1 0
6
 c e l l s
2  h 4  h 6  h 8  h 2  h 4  h 6  h 8  h 2  h 4  h 6  h 8  h 2  h 4  h 6  h 8  h
a p i c a l  9 9 . 4 9 8 . 8 9 8 . 7 9 7 . 8 9 9 . 5 9 9 . 4 9 8 . 8 9 8 . 9 9 9 . 4 9 8 . 7 9 8 . 6 9 7 . 2 - * 9 4 . 5 8 8 . 6 8 8 . 3
- * - *
- * - *
9 9 . 5 - * 9 8 . 8 9 9 . 0 9 8 . 2 9 8 . 5 9 8 . 4 9 7 . 3 9 7 . 3 9 4 . 9 9 0 . 8 9 0 . 3
- * - * 9 8 . 9 9 8 . 4 - * - * - * - * - * 9 8 . 5 9 8 . 6 9 7 . 4 9 7 . 4 9 5 . 1 9 1 . 3 9 0 . 9
m e a n 9 8 . 5 9 8 . 6 9 7 . 3 9 4 . 8 9 0 . 2 8 9 . 9
S D 0 . 1 0 . 1 0 . 1 0 . 3 1 . 4 1 . 3
i n t r a c e l l u l a r 0 . 4 0 . 5 0 . 6 0 . 5 0 . 3 0 . 4 0 . 7 0 . 3 1 . 1 n . d . n . d . n . d . 1 . 0 1 . 6 2 . 8 2 . 7
0 . 5 0 . 5 0 . 5 0 . 6 0 . 3 - * * 0 . 6 0 . 3 n . d . n . d . n . d . n . d . 1 . 0 1 . 8 2 . 5 3 . 1
0 . 4 0 . 5 0 . 5 0 . 5 0 . 3 0 . 4 0 . 5 0 . 3 n . d . n . d . n . d . n . d . 1 . 0 1 . 6 2 . 7 2 . 8
0 . 4 0 . 4 0 . 4 0 . 5 0 . 3 0 . 3 0 . 4 0 . 3
m e a n 0 . 4 0 . 5 0 . 5 0 . 5 0 . 3 0 . 3 0 . 5 0 . 3 1 . 0 1 . 7 2 . 7 2 . 8
S D 0 . 0 0 . 1 0 . 1 0 . 0 0 . 0 0 . 1 0 . 1 0 . 0 0 . 0 0 . 1 0 . 1 0 . 2
b a s a l 0 . 2 0 . 7 0 . 8 1 . 7 0 . 2 0 . 2 0 . 5 0 . 8 0 . 6 1 . 3 1 . 4 2 . 8 - * 3 . 9 8 . 5 9 . 0
- * - *
- * - *
0 . 1 - * 0 . 6 0 . 7 0 . 7 1 . 5 1 . 6 2 . 7 1 . 7 3 . 3 6 . 7 6 . 6
- * - * 0 . 6 1 . 1 - * - * - * - *
- *
1 . 5 1 . 4 2 . 6 1 . 7 3 . 3 6 . 0 6 . 3
m e a n 1 . 5 1 . 4 2 . 7 3 . 5 7 . 1 7 . 3
S D 0 . 1 0 . 1 0 . 1 0 . 4 1 . 3 1 . 5
M M A
V
D M A
V
M M M T A
V
D M M T A
V
-
 
48
 -
  
 
 
2 h 4 h 6 h 8 h 2 h 4 h 6 h 8 h 2 h 4 h 6 h 8 h 2 h 4 h 6 h 8 h
apical 99.6 99.5 99.1 98.6 97.3 97.9 98.3 -* -* -* 95.2 94.6 97.6 93.6 90.2 98.5
99.7 99.5 98.1 98.9 99.0 98.0 98.1 91.3 98.8 98.1 95.4 93.8 97.7 94.2 93.4 88.9
99.7 99.5 -* -* -* -* -* 89.9 98.6 97.8 94.9 92.2 98.1 93.6 94.2 89.0
mean 99.7 99.5 95.1 93.5 97.8 93.8 92.6 92.1
SD 0.1 0.0 0.2 1.2 0.3 0.4 2.1 5.5
intracellular 0.1 0.1 0.1 0.1 0.4 0.9 0.7 1.1 0.2 0.1 0.3 0.2 1.2 2.1 1.5 1.5
0.1 0.1 0.4 0.1 0.5 1.1 0.6 1.0 0.1 0.1 0.3 0.3 1.2 2.0 1.5 1.1
0.1 0.0 0.1 0.1 0.5 1.2 0.7 1.0 0.1 0.1 0.3 0.3 0.9 1.8 1.3 1.1
mean 0.1 0.1 0.2 0.1 0.5 1.1 0.7 1.1 0.1 0.1 0.3 0.3 1.1 2.0 1.4 1.2
SD 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2
basal 0.3 0.4 0.8 1.2 2.3 1.2 1.0 -* -* -* 4.6 5.2 1.2 4.3 8.3 0.0
0.2 0.4 1.5 0.9 0.4 1.0 1.3 7.7 1.0 1.8 4.4 5.9 1.1 3.8 5.1 10.0
0.3 0.4 -* -* -* -* -* 9.1 1.3 2.1 4.8 7.5 1.0 4.6 4.5 9.9
mean 0.3 0.4 4.6 6.2 1.1 4.2 6.0 6.6
SD 0.1 0.0 0.2 1.2 0.1 0.4 2.1 5.7
 all values presented in %As/106 cells
10 µM MTAV 10 µM MTAV - phosphate 10 µM TTAV TTAV - phosphate
2 h 4 h 6 h 8 h 2 h 4 h 6 h 8 h 2 h 4 h 6 h 8 h 2 h 4 h 6 h 8 h
apical -* 97.2 96.6 96.0 -* 98.3 98.3 97.4 -* 93.4 -* 88.9 94.6 88.8 82.8 79.3
97.9 97.2 96.7 96.8 98.5 98.3 98.2 97.2 96.3 93.3 93.6 90.6 95.4 89.4 83.8 83.9
97.9 99.2 97.1 96.6 98.5 98.8 98.2 97.3 96.2 93.2 94.1 90.9 95.1 89.9 83.7 83.6
mean 97.9 96.8 96.5 98.5 98.2 97.3 93.3 90.1 95.0 89.3 83.4 82.2
SD 1.2 0.2 0.4 0.3 0.1 0.1 0.1 1.1 0.4 0.5 0.5 2.6
intracellular 1.7 2.1 2.3 1.8 1.1 1.1 1.0 1.4 2.7 4.9 3.8 5.7 2.6 4.6 6.1 6.4
1.7 2.1 2.2 1.8 1.1 1.2 1.0 1.4 2.9 4.6 3.7 5.2 2.4 5.0 6.1 5.1
1.7 0.0 1.7 1.8 1.1 0.0 1.0 1.4 2.9 4.6 3.7 5.3 2.5 4.8 6.6 5.0
mean 1.7 1.4 2.1 1.8 1.1 0.8 1.0 1.4 2.8 4.7 3.7 5.4 2.5 4.8 6.3 5.5
SD 0.0 1.2 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.2 0.3 0.8
basal -* 0.8 1.1 2.2 -* 0.6 0.7 1.2 -* 1.8 -* 5.4 2.8 6.6 11.1 14.3
0.4 0.8 1.1 1.4 0.3 0.5 0.8 1.4 0.9 2.1 2.7 4.2 2.2 5.6 10.1 11.1
0.5 0.8 1.2 1.6 0.3 1.2 0.8 1.4 0.9 2.2 2.2 3.8 2.4 5.4 9.8 11.4
mean 0.8 1.1 1.7 0.8 0.7 1.3 2.0 4.5 2.5 5.9 10.3 12.3
SD 0.0 0.1 0.4 0.4 0.1 0.1 0.2 0.9 0.3 0.6 0.7 1.8
MMAV - phosphate DMAV - phosphate MMMTAV - phosphate DMMTAV - phosphate- 49 
-
  
 
T a b l e  S 2 :  T o t a l  c o n t e n t  o f  a r s e n i c  s p e c i e s  [ n g ]  t h a t  a r e  p r e s e n t  i n  a p i c a l  a n d  b a s a l  c o m p a r t m e n t s  a f t e r  i n c u b a t i o n  w i t h  a r s e n a t e ,  M T A
V
,  a n d  T T A
V  
 
t i m e  [ h ] 2 4 6 8 2 4 6 8
a r s e n i t e 0 . 9 1 . 8 1 . 2 1 . 1 6 . 8 5 . 6 5 . 6 7 . 4
a r s e n a t e 1 6 0 . 8 1 6 9 . 2 1 7 3 . 8 1 6 7 . 5 1 9 4 5 . 3 1 5 2 7 . 6 1 7 9 3 . 0 1 9 0 4 . 3
a r s e n i t e 1 . 7 0 . 8 3 . 4 2 . 6 1 . 4 1 . 6 2 0 . 3 1 . 2
a r s e n a t e 1 . 8 0 . 7 6 . 4 8 . 7 5 . 3 3 . 6 8 6 . 9 7 0 . 1
1  µ M  a r s e n a t e 1 0  µ M  a r s e n a t e
a p i c a l  [ n g ]
b a s a l  [ n g ]
t i m e  [ h ] 2 4 6 8 2 4 6 8
a r s e n i t e 9 . 8 7 1 2 . 4 6 1 4 . 0 6 2 1 . 2 0 6 7 . 4 9 7 2 . 6 1 9 0 . 0 5 1 4 6 . 3 4
a r s e n a t e 5 . 7 6 6 . 7 5 6 . 9 3 6 . 0 6 8 0 . 3 5 7 6 . 5 8 1 0 1 . 4 0 9 4 . 4 5
M T A
V
1 6 8 . 6 1 1 8 0 . 5 8 1 9 3 . 5 5 1 9 6 . 1 7 2 5 8 5 . 4 0 2 3 1 4 . 2 2 2 1 9 6 . 9 7 2 2 5 8 . 0 8
a r s e n i t e 0 . 4 4 0 . 8 2 1 . 8 0 0 . 9 9 0 . 6 6 1 . 3 7 4 . 7 2 5 . 4 3
a r s e n a t e 0 . 2 2 0 . 3 6 0 . 3 5 0 . 0 9 0 . 2 0 0 . 3 2 1 . 2 2 0 . 4 8
M T A
V
1 . 0 8 3 . 3 8 1 0 . 4 6 1 . 4 6 5 . 3 6 6 . 9 5 2 9 . 5 7 1 2 . 6 7
1  µ M  M T A
V
1 0  µ M  M T A
V
a p i c a l  [ n g ]
b a s a l  [ n g ]
t i m e  [ h ] 2 4 6 8 2 4 6 8
a r s e n i t e 7 0 . 0 5 6 2 . 3 9 6 2 . 8 8 6 2 . 6 1 5 0 1 . 6 6 5 4 4 . 5 2 3 9 2 . 1 2 7 3 4 . 0 3
a r s e n a t e 3 . 9 8 0 . 7 3 1 . 8 1 1 . 9 0 5 7 . 8 8 3 8 . 7 0 1 7 . 4 8 8 1 . 6 9
M T A
V
1 . 5 8 1 . 6 3 1 . 6 9 1 . 4 3 1 5 . 1 9 2 1 . 8 4 1 1 . 0 5 2 8 . 6 5
D i T A
V
3 2 . 7 6 2 2 . 6 8 2 5 . 8 3 2 2 . 5 4 1 1 9 . 6 5 1 1 5 . 5 3 1 5 8 . 6 8 1 6 4 . 7 5
T T A
V
8 7 . 8 8 7 0 . 2 5 6 3 . 2 7 4 7 . 8 2 1 0 7 9 . 1 8 1 0 5 1 . 1 5 3 8 0 . 4 8 9 6 7 . 2 2
a r s e n i t e 2 . 2 7 3 . 8 0 5 . 9 2 7 . 6 1 2 0 . 9 7 8 2 . 7 8 6 5 . 8 4 1 0 7 . 3 9
a r s e n a t e 0 . 0 1 0 . 0 2 0 . 0 6 0 . 2 1 0 . 0 8 2 . 3 9 3 . 0 7 5 . 7 8
M T A
V
0 . 0 1 0 . 0 1 0 . 0 5 0 . 0 1 0 . 1 5 0 . 9 6 0 . 1 5 0 . 8 0
D i T A
V
0 . 1 0 0 . 0 2 0 . 0 5 0 . 0 0 1 . 7 0 1 3 . 9 1 1 . 0 7 6 . 0 8
T T A
V
0 . 1 2 0 . 0 1 0 . 0 1 0 . 0 1 3 . 2 9 2 9 . 9 1 1 . 3 5 6 . 0 3
b a s a l  [ n g ]
1  µ M  T T A
V
1 0  µ M  T T A
V
a p i c a l  [ n g ]
-
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Table S3: Instrumental parameters for the separation of inorganic arsenic species by AEC 
analytical column IonPac AS-16 4-mm (Dionex) 
guard column IonPac AG-16 4-mm (Dionex) 
eluent 0.1 M NaOH 
flow rate 1.2 mL/min 
gradient [min] [mM] 
  0-7 20 
  7-17 20 → 100 
  17-25 100 
  25-28 20 
suppression ASRS-Ultra 4-mm (Dionex), 30 mA 
current, 5 mL/min water (external mode) 
 
Table S4: Instrumental parameters for the separation of methylated arsenic species by AEC 
 
 
 
 
 
 
 
 
 
  
analytical column IonPac AS-16 4-mm (Dionex) 
guard column IonPac AG-16 4-mm (Dionex) 
eluent 0.1 M NaOH 
flow rate 1.2 mL/min 
gradient [min] [mM] 
 0-3 2.5 
 3-5 2.5 → 20 
 5-10 20 
 10-20 20 → 100 
 20-24 100 → 2.5 
suppression none 
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Figure S1: TEER values monitored during transport experiments (2-8 h). All TEER values were > 500 Ωcm2 
indicating cell monolayer integrity during arsenic exposure. Each treatment was conducted in triplicate; 
presented values are mean values ± standard deviation 
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Figure S2: Apical, intracellular, and basal content of arsenic after incubation with 10 µM arsenite, arsenate, 
MTAV, and TTAV. Percentage share of arsenic in each compartment is referred to a number of 106 cells 
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 10 µM MTAV/TTAV in 
presence and absence of 
phosphate 
2.7 µM MMAV/DMAV in 
presence and absence of 
phosphate 
2.7 µM MMMTAV/ 
DMMTAV in presence and 
absence of phosphate 
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Figure S3: Apical, intracellular, and basal content of arsenic after incubation with 10 µM MTAV and TTAV and 
2.7 µM MMA, DMAV, MMMTAV, and DMMTAV. Transport of each arsenic species was quantified in the 
presence and in the absence of phosphate. Percentage share of arsenic in each compartment is referred to a 
number of 106 cells 
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Figure S4: Arsenic speciation in apical and basal medium after incubation with 1 and 10 µM MTAV; the crosses 
present the sum of arsenic species [µM] 
 
 
 
 
 
 
Figure S5: Arsenic speciation in apical and basal medium after incubation with 1 and 10 µM TTAV; the crosses 
present the sum of arsenic species [µM] 
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Figure S6: Arsenic speciation in apical and basal medium after incubation with 1 and 10 µM arsenate; the 
crosses present the sum of arsenic species [µM] 
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Figure S1: Separation of methylated arsenic species by AEC-ICP-MS. The blue lines represent standards diluted in 
ultrapure water, the red lines represent the respective standards diluted in cell growth medium. A: Calibration standard 
containing 10 µg/L of each arsenite, arsenate, MMAV, and DMAV; B: MMMTAV synthesis product with MMAV as 
original substrate; C: DMMTAV synthesis product with DMAV as original substrate 
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Abstract Arsenic, a common poison, is known to react with
sulfide in vivo, forming thioarsenates. The acute toxicity of
the inorganic thioarsenates is currently unknown. Our exper-
iments showed that a fourfold sulfide excess reduced acute
arsenite cytotoxicity in human hepatocytes (HepG2) and
urothelial cells (UROtsa) significantly, but had little effect
on arsenate toxicity. Speciation analysis showed immediate
formation of thioarsenates (up to 73 % of total arsenic) in case
of arsenite, but no speciation changes for arsenate. Testing
acute toxicity of mono- and trithioarsenate individually, both
thioarsenates were found to be more toxic than their structural
analogue arsenate, but less toxic than arsenite. Toxicity in-
creased with the number of thio groups. The amount of
cellular arsenic uptake after 24 h corresponded to the order
of toxicity of the four compounds tested. The dominant to
almost exclusive intracellular arsenic species was arsenite.
The results imply that thiolation is a detoxification process
for arsenite in sulfidic milieus. The mechanism could either be
that thioarsenates regulate the amount of free arsenite avail-
able for cellular uptake without entering the cells themselves,
or, based on their chemical similarity to arsenate, they could
be taken up by similar transporters and reduced rapidly intra-
cellularly to arsenite.
Keywords Thioarsenates .Monothioarsenate .
Trithioarsenate . UROtsa . HepG2 . Cytotoxicity
Introduction
Thioarsenates (AsVSnO4 − n
3− with n=1–4) are a group of
inorganic arsenic species which have been known since the
early nineteenth century to form in synthetic solutions of
arsenite and sulfide, but have only recently been discovered
to dominate in natural sulfidic environments. A number of
studies have appeared about their analysis (Planer-Friedrich
et al. 2010; Suess et al. 2009; Beak et al. 2008), stability in the
absence (Planer-Friedrich et al. 2007; Stauder et al. 2005;
Schwedt and Rieckhoff 1996) and presence of iron (Suess
and Planer-Friedrich 2012; Suess et al. 2011; Burton et al.
2013; Johnston et al. 2012), and abiotic and microbial trans-
formations (Härtig and Planer-Friedrich 2012; Planer-
Friedrich et al. 2009). Still little is known about the toxicity
of these species. The first to show that addition of sulfide
decreases arsenite toxicity was Rader et al. (2004) using a
simple test system with the marine bioluminescent bacteria
Vibrio fischeri. Based on existing thermodynamic constants
(Wilkin et al. 2003), Rader et al. (2004) predicted that
thioarsenites (AsIIISnO3 − n
3− with n=1–3) should form and
cause the decrease in arsenite toxicity. Unfortunately, the
thermodynamic constants used for the model turned out to
be wrong (Wallschläger and Stadey 2007; Planer-Friedrich
et al. 2010). The experiment was repeated later and the species
were identified correctly as thioarsenates (Planer-Friedrich
et al. 2008). Furthermore, the acute toxicity of mono-, di-,
Responsible editor: Philippe Garrigues
Electronic supplementary material The online version of this article
(doi:10.1007/s11356-014-2950-4) contains supplementary material,
which is available to authorized users.
S. Hinrichsen : R. Lohmayer :B. Planer-Friedrich (*)
Environmental Geochemistry, Bayreuth Center for Ecology and
Environmental Research (BayCEER), University of Bayreuth,
95440 Bayreuth, Germany
e-mail: b.planer-friedrich@uni-bayreuth.de
R. Zdrenka : E. Dopp
Institute of Hygiene and Occupational Medicine, University Hospital
Essen, Essen, Germany
Environ Sci Pollut Res (2014) 21:10151–10162
DOI 10.1007/s11356-014-2950-4
- 61 -
and trithioarsenate (MonoTAs(V), DiTAs(V), and
TriTAs(V)) for V. fischeri was tested with synthesized
standards. While MonoTAs(V) and DiTAs(V) were in fact
found to be less toxic than arsenite, TriTAs(V) turned out
to be as toxic as arsenite.
For humans, direct uptake of thioarsenates is unlikely, since
such sulfide-rich waters are generally non-potable. However,
the presence of free sulfide in concentrations up to 60 μmol/L
in the human gut lumen (Jorgensen and Mortensen 2001) can
lead to thioarsenate formation in vivo after uptake of arsenite.
The detection of methylated thioarsenates in urine samples of
rodents (Naranmandura et al. 2007b), but also humans (Raml
et al. 2007) that were exposed to arsenic, confirms an in vivo
methylation/thiolation process. Another study showed that
arsenate in a mouse cecum was microbially converted into
methylated (thio)arsenicals (monomethylarsenate (MMA(V)),
m o n om e t h y l - d i t h i o a r s e n a t e (MMDTA (V ) ) ,
dimethyldithioarsenate (DMDTA(V)), monomethyl-
trithioarsenate (MMTTA(V))), but also the inorganic
thioarsenates MonoTAs(V), DiTAs(V), and TriTAs(V) were
found (Pinyayev et al. 2011). For human fecal microbiota,
thiolation of arsenate to monomethylmonothioarsenate
(MMMTA(V)) (25 % of bioaccessible arsenic) and
MonoTAs(V) (in the absence of glutathione (GSH) and
methylcobalamin as methylating agent) was demonstrated
(Van deWiele et al. 2010). These evidences for the occurrence
of methylated and inorganic thioarsenates in vivo emphasize
that thioarsenate toxicity must be studied in systems which are
better suitable for predicting human toxicity than theV. fischeri
bioluminescence tests.
Some studies do exist about methylated thioarsenicals. In
MTT assays (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide) with human epidermoid carcinoma cells
(A431), dimethylmonothioarsenate (DMMTA(V)) was shown
to exhibit slightly lower acute cytotoxicity (IC50 5.7 μM) than
arsenite (IC50 10.7 μM) (Naranmandura et al. 2007a). Inter-
estingly, a further study with human bladder cells (EJ-1)
showed an opposite effect (IC50 16.7 and 112 μM) with the
additional finding of generation of reactive oxygen species
(ROS) in DMMTA(V)-treated cells, which was not observed
in arsenite-treated cells (Naranmandura et al. 2009). The num-
ber of thio groups was not associated to the toxicity of the
methylated thioarsenicals as shown in a study with human
hepatocytes (HepG2). DMMTA(V) was the most toxic com-
pound (IC50 0.026 mM), followed by dimethylarsenate
(DMA(V)) (IC50 0.343 mM) and DMDTA(V) (IC50
3.66 mM) (Ochi et al. 2008). In another study, the toxicity
of arsenic metabolites that were detected in urine was tested
on EJ-1 cells and resulted in the following order of toxicity:
dimethylarsenite (DMA(III)), DMMTA(V)>arsenite>arse-
nate>MMMTA(V)>MMA(V)>DMA(V)>DMDTA(V)
(Naranmandura et al. 2011). Different intracellular mecha-
nisms were detected when cells were exposed to DMMTA(V)
and arsenite. DMMTA(V) exposure led to reduced ex-
pression of the proteins p21 and p53, increased DNA
damage, reduced GSH level, and highly reactive oxygen
species (hROS), indicating oxidative cell death. In con-
trast, arsenite exposure resulted in increased expression
of p21 and p53, but no increase of GSH level, and no
hROS generation. Whether thiolation increases or de-
creases arsenic toxicity cannot clearly be assessed, yet,
but the existing studies already demonstrate different
cellular mechanisms when cells are exposed to arsenite
or methylated thioarsenicals.
No cell-based toxicity studies exist, yet, for inorganic
thioarsenicals, which was our motivation to investigate the
influence of sulfide on arsenite toxicity for HepG2 and
urothelial cells (UROtsa). We added sulfide to an arsenite
solution in a molar As/S ratio of 1:4 and analyzed arsenic
speciation in cell growthmedium after 6 and 24 h of exposure,
respectively, to determine the occurrence of inorganic
thioarsenates. The cytotoxicity of standard solutions of
Mono- and TriTAs(V) was measured and compared to the
cytotoxicity of their structural analogue arsenate and to arse-
nite to determine whether the formation of thioarsenates from
arsenite and sulfide is a process of detoxification. To evaluate
the influence of uptake on cytotoxicity, cellular uptake of
arsenite, arsenate, MonoTAs(V), and TriTAs(V) was quanti-
fied and compared to the order of toxicity of the four
compounds.
Materials and methods
Cell cultures
HepG2 and UROtsa cells were kindly provided by Prof. Dr. E.
Dopp (Institute of Hygiene and Occupational Medicine, Uni-
versity Hospital Essen, Germany). UROtsa cells were culti-
vated inminimum essential mediumwith Earle’s Salts (MEM,
c·c·pro, Oberdorla, Germany) supplemented with 10 % Fetal
Bovine Serum (FBS, Gibco), 0.5 % gentamycin (c·c·pro,
Oberdorla, Germany), and 1 % L-glutamine (c · c ·pro,
Oberdorla, Germany). HepG2 cells were grown in MEM
supplemented with 10 % FBS, 0.5 % gentamycin, 1 % L-
glutamine, 1 % non-essential amino acids, and 1 % sodium
pyruvate (all c·c·pro, Oberdorla, Germany). HepG2 and
UROtsa cells were incubated in a humidified atmosphere at
37 °C and 5% CO2 (Incubator Galaxy 170 S, New Brunswick
Scientific). Trypsin and trypsin–EDTA (0.25 %) were pur-
chased from c·c·pro (Oberdorla, Germany). As a result of a
recent research project, Johnen et al. (2013) have shown that
the UROtsa cells used in this study are in fact T24 cells. The
used cell line was intensively investigated and characterized
by these authors.
10152 Environ Sci Pollut Res (2014) 21:10151–10162
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Reagents
All reagents used were of the highest purity available, of at
least analytical-reagent grade, and they were sterile-filtered
before cell exposure. Sodium(meta)arsenite (AsNaO2), sodi-
um arsenate dibasic heptahydrate (AsHNa2O4 ·7H2O), and
sodium sulfide nonahydrate (Na2S·9H2O) were purchased
from Sigma-Aldrich (Steinheim, Germany). MonoTAs(V)
(Na3AsO3S·7H2O) and tetrathioarsenate (TetraTAs(V),
Na3AsS4·8H2O) were synthesized based on a modification
of previously published procedures (Schwedt and Rieckhoff
1996; Suess et al. 2009) with the exception that commercial
arsenic pentasulfide (As2S5, Santa Cruz Biotechnology, Inc,
Heidelberg, Germany) was used instead of self-synthesized
material for TetraTAs(V) synthesis. Based on speciation anal-
ysis by anion exchange chromatography coupled to an induc-
tively coupled plasma mass spectrometry (AEC-ICP-MS),
dissolving the synthesized MonoTAs(V) crystals in
Dulbecco’s Phosphate Buffered Saline (DPBS, GIBCO)
yielded more than 98 % MonoTAs(V). Dithioarsenate
(DiTAs(V)) could not be tested because it currently cannot
be synthesized as solid or liquid standard in sufficient (at least
>50 %) purity. The purity of TetraTAs(V) was greater than
90 % when dissolved in 0.1 M NaOH and re-analyzed by
AEC-ICP-MS. Dissolving TetraTAs(V) in DPBS yielded
more than 60 % TriTAs(V) but also 30 % arsenite due to the
pH instability of TetraTAs(V) (Planer-Friedrich and
Wallschlaeger 2009). Consequently, in the cytotoxicity as-
says, cells were principally exposed to TriTAs(V) as the
TetraTAs(V) standard was diluted in DPBS to ensure physio-
logical pH. For washing the cells prior to lysis, 2,3-
dimercapto-1-propanesulfonic acid sodium salt monohydrate
(DMPS, Alfa Aesar, Karlsruhe, Germany, purity 95 %),
DPBS, and autoclaved water (Ampuwa; Fresenius Kabi,
Bad Homburg, Germany) were used. Caution: The following
chemicals are human carcinogens and should be handled with
care: sodium(meta)arsenite, sodium arsenate dibasic
heptahydrate, and arsenic pentasulfide.
MTT cytotoxicity assay
In vitro acute cytotoxicity of the arsenicals was determined
using the MTTassay. The standard concentration range for all
arsenic species was 1–1,000 μM. In case IC50was not reached
at 1,000 μM, concentrations of 5,000 and 10,000 μM were
tested. The cells were seeded at a density of 5,000 cells per
well into 96 well plates (Falcon, Becton Dickinson, Meylan
Cedex, France), allowed to attach for 24 h, and subsequently
treated with the respective concentration of the desired arsen-
ical in fresh growth medium. For each experiment, the arsenic
solutions were prepared freshly and diluted in DPBS. All
experiments were at least conducted in triplicate with three
equally treated wells per replicate. After the respective
exposure duration, the medium was removed and the cells
were incubated for 2 h with 100 μL fresh medium and 10 μL
MTT (Sigma-Aldrich, USA). The formed formazan crystals
were dissolved in solubilization solution, consisting of 10 g
sodium dodecyl sulfate (SDS; Sigma-Aldrich, Steinheim,
Germany) dissolved in 99.4 mL dimethyl sulfoxide (DMSO;
Sigma-Aldrich, Steinheim, Germany) and 0.6 mL acetic acid
(C2H4O2; VWR PROLAB, Briare, France). The 96-well plate
was spectrophotometrically measured at 570 nm with a refer-
ence wavelength of 630 nm (Infinite 200 PRO, TECAN).
Absorbance measured in this test was finally correlated to
percent cell viability.
CV %½  ¼ 100
number of living cells
total number of cells
ð1Þ
Determination of IC50
Instead of the commonly applied procedure of estimating
an IC50 value by interpolating between measured data
points, we developed an independent statistical approach
to obtain reproducible means for an objective IC50
calculation.
The mean values of the calculated cell viability (Eq. 1),
including the standard deviation, were plotted as a function of
the logarithmic arsenic concentration of the respective species.
Since the decrease of cell viability with increasing concentra-
tions has the form of a smoothed-out step function in these
plots, the following function
f ðcÞ ¼ 50 erfc γlg
c
IC50
  
ð2Þ
was fitted to the data points, where c is the concentration, γ
and IC50 are fit parameters, and the function erfc(x) denotes
the complementary error function. As the values of this func-
tion range from 0 to 2, the complementary error function was
multiplied by 50 to ensure that the values of f(c) were between
0 and 100 (Eq. 2). The parameter γ determines the steepness
of the function f(c) in the vicinity of IC50, which represents the
concentration at which 50 % of the cells die. Figure 1 shows
the fitting on the basis of an MTTassay with HepG2 cells that
were exposed to 0.1–5000 μM arsenite for 24 h. The two
parameters γ and IC50 were determined using the Solver
function in Microsoft Excel. Therefore, the squares of the
deviations between the experimentally determined cell viabil-
ity and the corresponding values of f(c) were calculated and
weighted by the variance of the experimental values. Subse-
quently, the sum of these single values was minimized by
varying the fit parameters γ and IC50. It should be noted that
Environ Sci Pollut Res (2014) 21:10151–10162 10153
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the fitting only served for the determination of IC50 values.
Diagrams that represent the results of the MTT assays only
include the measured values.
Mechanical lysis of the cells
To determine arsenic uptake into the cells, 5×106 cells were
seeded 24 h before exposure to arsenite, arsenate,
MonoTAs(V), or TriTAs(V) at concentrations of 1 to 75 μM
in fresh growth medium. After 24 h of exposure, the medium
was collected. To ensure complete removal of extracellular
arsenic, the cell layer was rinsed four times using DPBS,
Ampuwa, 0.1 mM DMPS, and DPBS according to a pub-
lished procedure (Hippler et al. 2011). Subsequently, the cells
were trypsinized (trypsin–EDTA was used for HepG2 cells,
trypsin was used for UROtsa cells), collected in 2 mL DPBS,
counted with the CASYModel TT (Roche Applied Sciences),
and mechanically lysed using glass beads (Retsch GmbH,
Germany). The extracted cell lysates were analyzed without
further dilution. For each arsenic concentration, the cells were
exposed to, the analyzed intracellular arsenic content was
calculated for 1 Mio cells.
Analysis of total arsenic content and arsenic species
Inorganic arsenic species were analyzed using AEC-ICP-MS
(XSeries2, Thermo-Fisher) without anion suppressor. The
instrument parameters are listed in the supporting information.
Arsenic was determined as AsO+ (m/z = 91) using the dynam-
ic reaction cell (DRC) with O2 as reaction gas as described
before (Planer-Friedrich et al. 2007). Arsenite and arsenate
were quantified using standard solutions of the respective
solid. Thioarsenates were quantified on the basis of the arse-
nate calibration curve. Samples that were prepared for speci-
ation analysis were flash-frozen in liquid nitrogen and stored
in a freezer until analysis.
Total arsenic concentrations were determined by ICP-MS.
The results were corrected by an internal rhodium standard
(rhodium standard in 5 % HCl, 1,000 ppm, Ultra Scientific
Analytical Solutions, No. Kingstown, RI, USA) to compen-
sate changes in sensitivity. A total of 25 μL of the rhodium
standard was added per 5 mL sample. For stabilization until
analysis, the samples were acidified in 0.15 M HNO3.
Results
Cytotoxicity of arsenite and arsenate and the effect of sulfide
addition
Figure 2 shows the cell viabilities of HepG2 and UROtsa cells
that were incubated for 6 or 24 h with arsenite and
arsenate, respectively. For both cell lines and exposure
times, IC50 values were lower for arsenite than for arse-
nate indicating a higher acute toxicity of arsenite (Table 1).
The IC50 was not reached after 6 h at the highest arsenate
concentration tested (10,000 μM) in HepG2 cells. Adding
sulfide at a molar As/S ratio of 1:4 positively influenced
cell viabilities in case of arsenite for both cell lines in case
of 6 h incubation. For UROtsa cells, no more difference
between arsenite and arsenite–sulfide toxicity was ob-
served after 24 h, while for HepG2 cells the mediating
effect of sulfide on arsenite toxicity grew larger from 6 to
24 h (Fig. 2). The cell viabilities of HepG2 and UROtsa
cells that were incubated with arsenate were not signifi-
cantly influenced by addition of sulfide up to an arsenate
concentration of 1,000 μM (750 μM for UROtsa for 6 h).
Altogether, UROtsa cells were more susceptible than
HepG2 cells to arsenite and arsenate exposure.
Speciation analysis showed that arsenite and sulfide (molar
As/S ratio 1:4) in HepG2 growth medium instantly formed
between 36 and 73% thioarsenates, primarily TriTAs(V) (26–
57 %), besides DiTAs(V) (6–15 %) and some MonoTAs(V)
(1–5 %) (Fig. 3). No methylated thioarsenicals were detected.
The share of inorganic thioarsenates increased with increasing
total arsenic and corresponding sulfide concentrations, which
has previously been described to be an effect of an increasing
SH−/OH− ratio (Planer-Friedrich et al. 2010). Immediately
after mixing (t = 0 h), the solutions with the two highest
arsenic concentrations (500 and 1,000 μM) showed lower
shares of thioarsenates than the one with 250 μM, which is
likely a kinetic effect of retarded thioarsenate formation. After
6 and 24 h, all solutions with arsenic >250μM showed similar
shares of thioarsenates (Fig. 3). Thioarsenates have previously
been shown to be susceptible to oxygen and to be transformed
to arsenite over time (Planer-Friedrich et al. 2010). As thus
expected, the thioarsenate content decreased to <65 % after
6 h and to <33 % after 24 h (Fig. 3). The arsenic speciation
0
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Fig. 1 Cell viability of HepG2 after 24 h exposure to arsenite (10–
5,000 μM). The circles show the measured results of the MTT assay,
the continuous line shows the cell viability curve fitted with the modified
complementary error function (cf. Eq. (2))
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data for UROtsa growth medium were comparable to
the HepG2 growth medium data for 0, 6, and 24 h. The
AEC-ICP-MS analyses of arsenate and sulfide solutions
showed no change of arsenic speciation: all arsenic was
recovered as arsenate, no thioarsenates were formed
(data not shown).
a b
c d
HepG2 UROtsa 
6 h 
24 h 
6 h 
24 h
Fig. 2 Cell viabilities [% of
control, n = 3] of HepG2 and
UROtsa cells determined with
MTT assay after 6 and 24 h
exposure to arsenite, arsenate, and
each combined with sulfide in a
molar As/S ratio of 1:4; in each
experiment three wells were
treated with the same
concentration of the arsenic
species; a, c: HepG2 cells
exposed for 6 and 24 h,
respectively; b, d: UROtsa cells
exposed for 6 and 24 h,
respectively
Table 1 IC50 values (arsenic concentration at which the cell viability is
50%) of arsenite, arsenate, MonoTAs(V), and TriTAs(V) for UROtsa and
HepG2 cells after 24 and 6 h of exposure; standard concentration range of
exposure was 10 to 1,000 μM; IC50 >1,000 μM could be determined by
testing 5,000 and 10,000 μM in case IC50 was not reached at 1,000 μM.
IC50 <10 μM could be determined by testing 0.1 and 1 μM
HepG2 UROtsa
IC50 (6 h) [μM] IC50 (24 h) [μM] IC50 (6 h) [μM] IC50 (24 h) [μM]
Arsenite 287 72 125 4
Arsenate >10,000 3,914 552 166
MonoTAs(V) 1,573 371 599 48
TriTAs(V) 719 142 162 20
Arsenite/sulfide 1:4 961 186 1,186 11
Arsenate/sulfide 1:4 1,501 952 977 161
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Cytotoxicity of MonoTAs(V) and TriTAs(V) in comparison
to arsenite and arsenate
Since thioarsenates were shown to form upon addition of
sulfide to arsenite solutions, toxicity of the available
thioarsenate standards MonoTAs(V) and TriTAs(V) was
tested. As standard procedure, only concentrations up to
1,000 μM arsenic were tested and led to cell viabilities
<20 % for most arsenic species. In some cases, when
higher concentrations were applied, an apparent re-
increase in cell viabilities was observed for MonoTAs(V)
and TriTAs(V). By microscopic cell-counting, cell death
at these high concentrations was confirmed. The apparent
re-increase in cell viabilities is thus attributed to a reac-
tion of the thioarsenates themselves or a sulfur compo-
nent formed from the thioarsenates with MTT which
could be observed for a rsen ic concen t ra t ions
≥1,000 μM in cell-free medium (data not shown). The
respective data points were therefore removed from the
following graphs. Figure 4 shows the acute cytotoxicity
of MonoTAs(V) and TriTAs(V) in comparison to arsenite
and arsenate. In the applied concentration range of 10–
1,000 μM arsenic, UROtsa cells were more susceptible
to exposure of arsenite, arsenate, MonoTAs(V), and
TriTAs(V) than HepG2 cells. In both cell lines, the
cytotoxicity of all arsenic species increased with time.
Based on the cytotoxicity curves (Fig. 4) and the respec-
tive IC50 values, the order of acute cytotoxicity was
determined for both cell lines as follows: arsenite >
TriTAs(V) > MonoTAs(V) > arsenate (Table 1).
Figure 5 shows the stability of the thioarsenate stan-
dards during cell exposure times. Under the conditions
applied (37 °C, 5 % CO2), TriTAs(V) in growth medium
was shown not to be completely stable. Directly after
adding the TriTAs(V) standard to the HepG2 growth
medium, 66 % of total arsenic was analyzed as TriTAs(V)
(72 % in UROtsa growth medium). The content of
TriTAs(V) was reduced to 52 % after 6 h and to 30 %
after 24 h (45 and 28 % in UROtsa growth medium,
respectively) (Fig. 5). The conversion of TriTAs(V) with
time led to an assimilation of the toxicity curves of arse-
nite and TriTAs(V) (Fig. 4). MonoTAs(V) in growth me-
dium was more stable than TriTAs(V). The initial
MonoTAs(V) percentage in HepG2 growth medium of
87 % (90 % in UROtsa growth medium) decreased to
66 % after 6 h and to 53 % after 24 h of incubation (61
and 56 % for UROtsa growth medium, respectively)
(Fig. 5).
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Fig. 3 Arsenic speciation in HepG2 growth medium after exposure (6
and 24 h) to arsenite and sulfide at a molar ratio of As/S 1:4; t = 0
represents the arsenic speciation in medium directly after adding arsenite
and sulfide
10156 Environ Sci Pollut Res (2014) 21:10151–10162
- 66 -
HepG2 UROtsa 
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a b
c d
6 h 
24 h 
Fig. 4 Cell viabilities [% of
control, n = 3] of HepG2 and
UROtsa cells determined with
MTT assay after 6 and 24 h
exposure to arsenite, arsenate,
MonoTAs(V), and TriTAs(V)
(10–10,000 μM); in each
experiment, three wells were
treated with the same
concentration of the arsenic
species; a, c: HepG2 cells
exposed to the arsenic species for
6 and 24 h, respectively; b, d:
UROtsa cells exposed to the
arsenic species for 6 and 24 h,
respectively
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Fig. 5 Arsenic speciation in
HepG2 and UROtsa growth
medium after 6 and 24 h of
exposure to 100 μM
MonoTAs(V) and 100 μM
TriTAs(V)
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Cellular uptake of Mono- and TriTAs(V) in comparison
to arsenite and arsenate
In order to determine whether the observed differences in
toxicity between arsenite, TriTAs(V), MonoTAs(V), and arse-
nate can be explained simply by different concentrations in the
cells, cellular uptake was determined. After 24 h of exposure to
the different arsenic species (0.1–100 μM), arsenic concentra-
tions in medium, washing solutions, and cells were quantified.
Arsenic recovery rate was 105 ± 13% forHepG2 cells and 103 ±
5 % for UROtsa cells. Since cells were considerably damaged
when treated with 100 μM of any arsenic species, a reliable cell
counting with the CASY TT was not practicable and arsenic
uptake could only be quantified up to 75 μM. The uptake of
arsenite and TriTAs(V) per single cell was higher in HepG2
cells than in UROtsa cells, whereas the uptake ofMonoTAs(V)
and arsenate was higher in UROtsa cells. The order of arsenic
uptake was determined for HepG2 cells as arsenite > TriTAs(V)
> MonoTAs(V) > arsenate and for UROtsa cells as arsenite ≈
TriTAs(V) > MonoTAs(V) > arsenate (Fig. 6).
Speciation analysis showed that after 24 h of exposure, the
speciation of both arsenite and arsenate was unchanged in the
cell culture media of both UROtsa and HepG2 cells (≥98% of
the original species). Incubation with TriTAs(V) yielded 6–29%
TriTAs(V), 1–10%DiTAs(V), and 71–89% arsenite inmedium
after 24 h for HepG2 cells, which was comparable to the
speciation in UROtsa growth medium. Speciation of
MonoTAs(V) in growth medium slightly differed after 24 h
incubation among HepG2 and UROtsa growth medium. More
MonoTAs(V) was transformed into arsenite in UROtsa growth
medium as compared to HepG2 growth medium (HepG2: 58–
69 % MonoTAs(V), 17–31 % arsenite, 9–13 % arsenate;
UROtsa: 42–52 % MonoTAs(V), 34–45 % arsenite, 12–13 %
arsenate) (Online Resource Fig. SI-1). Intracellularly, arsenic
was determined to be mainly arsenite. In arsenite-exposed cells,
arsenite represented more than 97 % in HepG2 cells and more
than 87 % of total arsenic in UROtsa cells (exception at expo-
sure to 1 μM arsenite: 57 % arsenite, the rest arsenate, which
might be attributed to the greater instability of species in the
more dilute solution). In arsenate-exposed cells, more than 67%
arsenate was reduced to arsenite in both cell lines, whereat in
UROtsa cells generally more arsenate was found. In cells treated
with MonoTAs(V), more than 98 % of arsenic was found as
arsenite (exception at 1 μM MonoTAs(V): 57 % arsenite in
HepG2, 82 % arsenite in UROtsa cells, the rest arsenate).
TriTAs(V) was found to be transformed into more than 97 %
arsenite in both cell lines (Online Resource Fig. SI-2).
Discussion
In general, the results of our studies on arsenite and arsenate
cytotoxicity are in accordance with previous literature (Dopp
et al. 2008; Styblo et al. 2000) and show arsenite to be more
toxic than arsenate for UROtsa and HepG2 cells. In
comparison to data published by Dopp et al. (2008) using
trypan blue staining to assess cytotoxicity (IC50 arsenite
170 μM, IC50 arsenate >500 μM), our results showed a
higher toxicity for both arsenite and arsenate as a result of
the higher sensitivity of the MTT assay compared to trypan
blue staining. However, the results are in the same range as the
values from Styblo et al. (2000) (IC50 arsenite 17.8 μM, IC50
arsenate >20 μM, determined with MTT assay). The deter-
mined IC50 value of 72μM for HepG2 cells following arsenite
exposure for 24 h agrees well with the value of 90.5 ± 6.5 μM
published by Qu et al. (2009), who used the MTS assay
(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium) to determine cell viabil-
ities. Altogether, UROtsa cells were shown to be more
susceptible than HepG2 cells to both arsenite and arsenate
a
b
Fig. 6 Arsenic uptake in HepG2 (a) and UROtsa cells (b) after 24 h of
exposure to arsenite, arsenate, MonoTAs(V), and TriTAs(V); intracellular
arsenic content [μg] was calculated for 1 Mio cells
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exposure which is expressed in generally lower IC50
values and a stronger decrease of cell viabilities between
6 and 24 h of exposure for UROtsa cells as compared to
HepG2 cells.
No data existed so far about the influence of sulfide on the
acute cytotoxicity of arsenate and arsenite, or, specifically, the
acute cytotoxicity of thioarsenates. In agreement with previ-
ous publications (Planer-Friedrich and Wallschlaeger 2009;
Rochette et al. 2000), the presence of sulfide in arsenate
solutions did not induce any speciation changes at physiolog-
ical pH. Specifically, it did not lead to formation of
thioarsenates. Expectedly, cell viabilities of UROtsa cells
exposed to arsenate–sulfide mixtures and arsenate alone did
not differ significantly. At concentrations of >1,000 μM
arsenate and >4,000 μM sulfide, cell viabilities of HepG2
cells were substantially lower when cells were exposed to
arsenate and sulfide as compared to arsenate alone. That
sulfide exerts a cytotoxic effect at these concentrations is in
line with Caro et al. (2011) who observed a decrease in cell
viability of 34 ± 3 % at 200 μM NaHS.
In contrast to observations in arsenate solutions, the pres-
ence of sulfide did significantly decrease the acute cytotoxic-
ity of arsenite solutions. Our data show a clear reduction of
arsenite cytotoxicity in HepG2 cells after 6 and 24 h of
exposure and in UROtsa cells after 6 h of exposure by addition
of sulfide (As/S ratio 1:4). Formation of thioarsenates up to
73 % of total arsenic was observed. TriTAs(V) was the dom-
inant species (up to 57%). The share of thioarsenates declined
with time and after 24 h of incubation only 33 % of all arsenic
was present as thioarsenates, the rest was detected as arsenite.
The conversion of thioarsenates to arsenite with time might
account for the marginal difference of toxicity in UROtsa cells
concurrently treated for 24 h with arsenite and sulfide versus
arsenite only. Though exposed to the same substances with the
same problem of thioarsenate conversion, this effect was not
observed in HepG2 cells. We suggest that the higher suscep-
tibility of UROtsa cells implicating a faster reaction to arsenite
exposure compared to HepG2 cells accounted for the approx-
imation of the toxicity of arsenite–sulfide mixtures versus
pure arsenite solutions with time. A further explanation for
the differences observed upon sulfide addition to arsenite
solutions for HepG2 and UROtsa cells relates to the antioxi-
dant properties of sulfide. One mechanism of arsenite cyto-
toxicity is the production of reactive oxygen species (Eblin
et al. 2006; Smith et al. 2001; Scott et al. 1993). Sulfide as an
antioxidant can counteract oxidative stress in cells, e.g., by
increasing the intracellular GSH level (Kimura et al. 2006,
2011, 2012; Yonezawa et al. 2007; Xiao et al. 2012; Fan et al.
2013; Wen et al. 2013). Since radical formation was shown to
be more pronounced in human hepatocytes than in urothelial
cells (Dopp et al. 2008), this might explain the more pro-
nounced positive effect of sulfide on HepG2 cells exposed
to arsenite for 24 h in contrast to UROtsa cells, too.
Experiments with individual standards of MonoTAs(V)
and TriTAs(V) showed that both thioarsenates were more
toxic than their structural analogue arsenate. However, they
were considerably less toxic for both cell lines and exposure
times than arsenite, from which they naturally form in the
presence of sulfide. The decreased toxicity as compared to
arsenite was more pronounced for MonoTAs(V) than for
TriTAs(V). The interpretation of the toxicity of TriTAs(V)
must take into account that the initially applied TriTAs(V)
standard already contained 30 % arsenite as an impurity. In
our own experiments with HepG2 and UROtsa cells, we
found, in accordance with previous literature on rat urothelial
cells (Nascimento et al. 2008), that application of two different
arsenic compounds leads to additive acute cytotoxic effects
(data not shown). Even considering this additive toxic effect
of a 30% arsenite impurity in our original TriTAs(V) solution,
the toxicity of a calculated “pure” TriTAs(V) solution still is
significantly lower than that of arsenite and higher than that of
MonoTAs(V).
Overall, thiolation can be seen as a process of detoxifica-
tion for UROtsa and HepG2 cells with respect to the originally
existing arsenite (not compared to the structural analogue
arsenate!). The observed increase of toxicity with a higher
number of thio groups is in contrast to an earlier study with
HepG2 cells that did not show a connection between the
number of thio groups and their toxicity for methylated
thioarsenicals (Ochi et al. 2008). However, it is in accordance
with a toxicity study (Planer-Friedrich et al. 2008), in which
the marine bioluminescent bacterium V. fischeri was exposed
to the same arsenic and arsenic–sulfur compounds as in the
present study. To reliably assess the influence of the number of
thio groups on thioarsenate toxicity, testing of Di- and
TetraTAs(V) standards would be necessary. However,
DiTAs(V) can currently not be synthesized in sufficient purity
and TetraTAs(V) is only stable at highly alkaline pH. As
observed for arsenite and arsenate, the toxicity of the
thioarsenates increased with time and this effect was more
pronounced in UROtsa cells than in HepG2 cells. Since the
actual thioarsenic speciation in growth medium did not sub-
stantially differ between HepG2 and UROtsa cells, this effect
can be attributed to the different susceptibilities of the two
used cell lines.
To assess what explains the different cytotoxicity of the
four investigated arsenic species, uptake after 24 h of exposure
and intracellular speciation were determined. Even when ex-
posed to arsenate, the dominant intracellular arsenic species
was arsenite (up to 90 % for UROtsa, up to 93 % for HepG2
cells). Since arsenate in the cell growth medium was stable
during 24 h of exposure, we assume that arsenic was actually
taken up as arsenate and reduced inside the cells by GSH
(Delnomdedieu et al. 1994) or in the case of HepG2 cells by
As(V)reductase (Radabaugh and Aposhian 2000). The differ-
ences in arsenite and arsenate toxicity must thus be caused by
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different amounts of uptake. In fact, when exposing both cell
lines to the same concentrations, arsenate uptake was lower
than the arsenite uptake up to a factor of 40 for UROtsa cells
and 65 for HepG2 cells. These results correspond to an earlier
study where HepG2 cells were exposed for 1 h to 50 μM
arsenic and uptake was 1.54 ± 0.03 ng/106 cells for arsenate
but 10.71 ± 0.07 ng/106 cells for arsenite (Dopp et al. 2005).
The lower uptake of arsenate compared to arsenite can be
explained by different uptake mechanisms: arsenite is taken
up by cells via aquaglyceroporins (Shinkai et al. 2009; Liu
et al. 2004) or via diffusion because it is uncharged at phys-
iological pH (pKa1, 9.23) (Lerman et al. 1983). In contrast,
arsenate (pKa1, 2.19; pKa2, 6.94) is taken up by inorganic
phosphate transporters and therefore competes with the uptake
of phosphate. Arsenate uptake was shown to be reduced up to
90 % in the presence of 1 mM inorganic phosphate, which is
the concentration of extracellular inorganic phosphate in
mammals maintained by homeostatic mechanisms (Villa-
Bellosta and Sorribas 2010). The buffer solution DBPS used
in the toxicity tests to dissolve the arsenic compounds also
contains inorganic phosphate in a considerable amount
(1.46 mM potassium phosphate monobasic and 8.06 mM
sodium phosphate dibasic). The correlation between reduced
uptake and reduced toxicity was also used by Dopp et al.
(2005) to explain for HepG2 cells the lower cytotoxicity of
pentavalent methylated compared to inorganic and trivalent
methylated species.
No information existed about the amounts or mechanisms
for the cellular uptake of thioarsenates, yet. Based solely on
charge, uptake of MonoTAs(V) (pKa2 = 7.2 (Thilo and
Hertzog 1970)) should be similar to that of arsenate. At
physiological pH, TriTAs(V) dominates as twofold negatively
charged complex (pKa3, 10.8 (Thilo and Hertzog 1970)), even
though its fate is also determined by its instability with trans-
formation to arsenite over time (Planer-Friedrich and
Wallschlaeger 2009). Like for arsenate exposure, the only
arsenic species observed inside the cells was arsenite when
cells were exposed to Mono- or TriTAs(V). The order of
cellular uptake was mainly consistent with the order of cyto-
toxicity for HepG2 and UROtsa cells, namely arsenite >
TriTAs(V) > MonoTAs(V) > arsenate. For UROtsa cells,
uptake of arsenite and TriTAs(V) did not differ significantly.
As shown before, 70–90 % of the originally added
trithioarsenate transformed to arsenite after 24 h in the medi-
um. For MonoTAs(V), 17–31 % arsenite had formed in
HepG2 and 34–45 % in UROtsa growth medium. Interesting-
ly, total arsenic concentrations detected intracellularly were
higher for UROtsa (0.11 μg/106 cells at 75 μMMonoTAs(V))
than for HepG2 cells (0.06 μg/106 cells), which might be
related to the higher share of arsenite in medium. Taken
together, it currently remains unclear whether thioarsenates
are taken up as thioarsenates—which seems likely given their
chemical similarity to arsenate—followed by intracellular
reduction or first reduced in the medium and then taken up
as arsenite exclusively. Certainly, the mediating effect of
thioarsenate formation on arsenite toxicity must be considered
in light of their instability under changing pH conditions and
in the presence of oxygen with transformation to either arse-
nite or arsenate. Further studies on the precise nature of
cellular uptake and intracellular reactions as well as on the
chronic toxicity of thioarsenates at environmentally relevant
low concentrations are currently underway in our laboratory.
Conclusion
In the present study, we showed that acute arsenite cytotoxic-
ity was significantly reduced in HepG2 and UROtsa cells in
the presence of sulfide due to formation and transformation of
thioarsenates. Over time, the mediating effect of thioarsenates
decreased. The order of acute cytotoxicity (arsenite >
TriTAs(V) > MonoTAs(V) > arsenate) correlated with the
amount of uptake but uptake alone was not sufficient to fully
explain the observed differences in cytotoxicity. Intracellular-
ly, arsenic was observed almost exclusively as arsenite.
Whether sulfide merely decreases the amount of cellular
available, cytotoxic free arsenite by extracellular formation
of thioarsenates, or thioarsenates are actively transferred into
the cell and undergo intracellular transformation to arsenite,
remains subject to future investigation. However, our study
clearly showed that thiolation and the subsequent toxicity of
thioarsenates will have to be considered in studies about
arsenic toxicity.
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Fig. SI- 1 Arsenic species [% of total arsenic] in HepG2 and UROtsa growth medium after 24 h of exposure to 
arsenite, arsenate, MonoTAs(V), and TriTAs(V) (1-75 µM) 
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Fig. SI- 2 Intracellular arsenic species [% of total arsenic] in HepG2 and UROtsa cells after 24 h of exposure to 
arsenite, arsenate, MonoTAs(V), and TriTAs(V) (1-75 µM) 
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Tab. SI – 1 Instrumental parameters for the separation of arsenic species by anion exchange chromatography 
 
analytical column IonPac AS-16 4-mm (Dionex) 
 
guard column IonPac AG-16 4-mm (Dionex) 
 
eluent 0.1M NaOH 
 
gradient   [min]               [mM] 
   0 - 7                 20 
   7-17             20 → 100 
 17 - 25              100 
 25 - 28               20 
 
flow rate 1.2 mL/min 
suppression none 
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ABSTRACT: Based on acute cytotoxicity studies, selenosulfate (SeSO3
-) has been suggested to possess a generally higher 
toxic activity in tumor cells than selenite. The reason for this difference in cytotoxic activity remained unclear. In the 
present study, cytotoxicity tests with human hepatoma (HepG2), malignant melanoma (A375), and urinary bladder carci-
noma cells (T24) showed that the selenosulfate toxicity was very similar between all three tested cell lines (IC50 6.6-7.1 µM 
after 24 h). It was largely independent of exposure time and presence or absence of amino acids. What changed, however, 
was the toxicity of selenite, which was lower than that of selenosulfate only for HepG2 cells (IC50 > 15 µM), but similar to 
and higher than that of selenosulfate for A375 (IC50 4.7 µM) and T24 cells (IC50 3.5 µM), respectively. Addition of amino 
acids to T24 cell growth medium down-regulated short-term selenite uptake (1.5 versus 12.9 ng Se /106 cells) and de-
creased its cytotoxicity (IC50 8.4 µM), rendering it less toxic than selenosulfate. The suggested mechanism is a stronger 
expression of the xc
- transport system in the more sensitive T24 compared to HepG2 cells which creates a reductive extra-
cellular microenvironment and facilitates selenite uptake by reduction. Selenosulfate is already reduced and so less affect-
ed. The cytotoxic activity of selenosulfate and selenite to tumor cells therefore depends on the sensitivity of each cell line, 
supplements like amino acids as well as the reductive state of the extracellular environment.  
Introduction 
Selenium (Se) is an essential trace element for humans. Var-
ious selenium compounds are known to possess anticarcino-
genic properties, e.g. selenite (Na2SeO3) is often used in clini-
cal trials as addition to commonly applied anti-cancer chemo-
therapy drugs (Dennert &Horneber 2006). High concentra-
tions of the anti-cancer drug cisplatin can result in different 
side effects such as leucocyte reduction, diarrhea, vomiting, 
edema, or nephrotoxicity. As an essential antioxidant selenite 
can reduce the toxicity of cisplatin without compromising its 
anticarcinogenic activity as shown in animal studies (Baldew 
et al. 1989, Camargo et al. 2001, Markovic et al. 2011). How-
ever, high doses of selenite have been shown to exert strong 
cytotoxic effects themselves, e.g. on prostate (Li et al. 2007), 
ovarian (Park et al. 2012a), liver (Shen et al. 1999), or lung 
cells (Park et al. 2012b). Due to the narrow concentration 
range between beneficial and toxic effects and a potential 
negative influence also on healthy tissue, application of sele-
nite in cancer treatment is still discussed quite controversially 
(Micke et al. 2009, Vinceti et al. 2001, Zhang et al. 2008b).  
A recent patent (Patent US 2010/0172822) claims selenosul-
fate (Na2SeSO3) to be preferable over selenite and suggests its 
use as complementary substance in anti-cancer therapy (Zhang 
2010). Mice studies showed that selenosulfate effectively 
reduced gastrointestinal toxic effects induced by cisplatin from 
80 to 6% (Li et al. 2012) without disturbing its therapeutic 
effect on tumor cells (Zhang et al. 2008b). In addition, while 
long-term (55 d) administration of selenite resulted in dose-
dependent growth suppression and hepatoxicity in mice, sele-
nosulfate administration in the same concentrations (12.7 and 
19 µM) did not result in toxic symptoms (Li et al. 2012). That 
means while being as efficient as selenite in reducing negative 
side effects of chemotherapy drugs such as cisplatin, seleno-
sulfate is less toxic to healthy tissue, thus, higher doses can be 
applied. 
An interesting side effect in selenite-based cancer therapy is 
that cell culture studies suggest selenite to have a higher cyto-
toxicity in tumor cells compared to healthy cells, shown e.g. in 
studies on human malignant glioma (Kim et al. 2007) and 
osteosarcoma cells (Chen et al. 2012) versus comparable 
healthy cells. The differences in toxicity for tumor versus 
healthy cells are mainly explained by different uptake mecha-
nisms, which in turn are governed by the extracellular reduc-
tive capacity (lm et al. 2009). The redox state of the extracel-
lular environment largely depends on the cysteine/glutamate 
exchange system (xc-) first identified by Bannai et al. (1986) 
and the presence of multidrug resistance proteins (MRP) 
which are overexpressed in many tumor cell lines (reviewed in 
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Conrad &Sato 2012). The xc--overexpression drives the in-
tracellular cystin/cysteine redox cycle. Cysteine is then in-
creasingly secreted by MRP into the extracellular environment 
and induces increased selenium uptake by formation of more 
reduced selenium compounds, especially HSe-. Both HSe- and 
selenite enter the cells by anion channels, but there is a higher 
affinity for HSe- (Conrad &Sato 2012). A strong relationship 
was found between extracellular thiol production, selenite 
uptake, and cellular susceptibility to selenite in different lung 
tumor cells (Olm et al. 2009). Selenite uptake was increased 
by extracellular reduction through e.g. GSH addition and 
decreased by extracellular oxidation (through addition of 55’-
dithiobis-(2-nitrobenzoic acid)) (Olm et al. 2009). Addition of 
extracellular thiols also increased selenite uptake in a 
keratinocyte model (Ganyc &Self 2008). Amino acids might 
decrease selenite uptake, at least the reverse process of selenite 
decreasing the uptake of amino acids was confirmed previous-
ly (Hogberg &Kristoferson 1979, Vernie et al. 1974). An 
influence of amino acids on selenite uptake actually generates 
a problem when comparing cytotoxicity data of different cell 
culture studies. Numerous different cell growth media compo-
sitions have been used for growing the same cell line and non-
essential amino acids (NEAA) have been added in some stud-
ies (McKelvey et al. 2015, Zhang et al. 2008a) but not in oth-
ers (Chu &Crawford-Brown 2006, Peng et al. 2007, Zou et al. 
2007) without separating pure selenite from combined sele-
nite-NEAA effects. 
For selenosulfate, patent US 2010/017282 claims that it has 
an even higher activity than selenite to suppress and kill spe-
cifically tumor cells (Zhang 2010) which would be another 
advantage of its preferred application. The claim is based on 
acute cytotoxicity tests in cell culture studies with human 
hepatocellular carcinoma (HepG2), epithelial colorectal ade-
nocarcinoma (Caco-2), and three different kinds of leukemia 
cells (HL60, T lymph adenoma, Daudi) (Zhang et al. 2008a). 
The amount of intracellular uptake or the effect of extracellu-
lar compounds on cytotoxicity and uptake were not investigat-
ed and no reason was given as to what could have caused the 
difference in cytotoxic activity between selenosulfate and 
selenite. 
The goal of the present study was therefore to repeat the 
previously published cytotoxicity tests (Zhang et al. 2008a) to 
see if this claim can really be generalized to different types of 
tumor cells and to elucidate why selenosulfate should be more 
toxic than selenite. Besides human hepatoma cells (HepG2), 
which were selected for comparison with the previous studies 
(Zhang 2010, Zhang et al. 2008a), we tested two further tumor 
cell lines: Malignant melanoma (A375) and urinary bladder 
carcinoma cells (T24). The T24 cells were selected because 
high selenium levels in the body have been shown to be in-
versely correlated with bladder cancer risk (Kellen et al. 2006) 
and selenium is discussed to act as chemopreventive agent 
against bladder cancer (Brinkman et al. 2006). The A375 cells 
were selected because previous experiments related the pres-
ence of different selenium compounds - selenium nanoparti-
cles (Chen et al. 2008), selenocystine (Chen &Wong 2008), 
and 1,4-Diselenophene-1,4-diketone (Vinceti et al. 2014) – to 
oxidative stress and mitochondrial dysfunction leading to 
apoptosis in A375 cells. Furthermore, selenium compounds 
were found to be able to enhance X-ray induced growth inhibi-
tion in A375 cells (Lo et al. 2008).  
Using these three different cell lines, we compared cytotox-
icity of selenosulfate and selenite for three different incubation 
times (24, 48, and 72 h) and, for HepG2 and T24 cells, in the 
presence and absence of NEAA as medium supplement. We 
also determined intracellular selenium concentrations to inves-
tigate the relation between uptake and respective selenium 
cytotoxicity.  
Materials and methods 
Synthesis and stability of selenosulfate standards  
Selenosulfate was synthesized according to a published proce-
dure (Zhang et al. 2008a). Briefly, selenite (Fluka Analytical, 
Steinheim, Germany), glutathione (GSH, Applichem, Darm-
stadt, Germany), and sulfite (Sigma-Aldrich, Steinheim, Ger-
many) were mixed in a molar ratio of 1:4:4 and gently homog-
enized until the solution was clear. The purity of the standard 
(91.7 ± 9.9%, rest on average 6.8% selenite and 1.5% selenate) 
was determined by speciation analysis using anion exchange 
chromatography (Dionex) with an AS16 column, a 0.02-0.1 M 
NaOH-eluent and no anion suppressor, coupled to an induc-
tively coupled plasma mass spectrometry (AEC-ICP-MS, 
XSeries2, Thermo-Fisher). The method had previously been 
described for separation of thioarsenates and thioantimonates 
(Planer-Friedrich et al. 2007). In the experimental solutions 
themselves we could not determine selenium speciation chro-
matographically due to interferences from the applied cell 
growth medium. Pretests under cell cultivation conditions 
(37° C, 5% CO2) showed after 72 h no precipitation of ele-
mental red selenium which had previously been taken as an 
indication of selenosulfate instability (Zhang et al. 2008a). We 
therefore conclude that selenosulfate was stable during all our 
experiments.  
Cell cultures 
Both HepG2 and T24 cells were kindly provided by Prof. 
Dr. E. Dopp (Institute of Hygiene and Occupational Medicine, 
University Hospital Essen, Germany). The T24 cell line was 
primarily assumed to be the UROtsa cell line which is a non-
tumorigenic urothelial cell line. However, several stocks of 
UROtsa cells were cross-contaminated and were recently 
identified as bladder tumor cell line T24 (Johnen et al. 2013). 
The A375 cells were purchased from CLS Cell Lines Service 
GmbH (Eppelheim, Germany). The HepG2 cells were grown 
in minimum essential medium with Earle’s Salts (MEM, 
c·c·pro, Oberdorla, Germany) supplemented with 10% FBS, 
0.5% gentamycine, 1% L-glutamine, 1% NEAA, and 1% 
sodium pyruvate (all c·c·pro, Oberdorla, Germany). The T24 
cells were cultivated in MEM supplemented with 10% Foetal 
Bovine Serum (FBS, Gibco), 0.5% gentamycine (c·c·pro, 
Oberdorla, Germany), and 1% L-glutamine (c·c·pro, Oberdor-
la, Germany). The A375 cells were cultivated in Dulbecco’s 
modified Eagle Medium (DMEM, c·c·pro, Oberdorla, Germa-
ny) supplemented with 10% FBS, 1% L-glutamine, and 1% 
penicillin-streptomycin (DMEM, c·c·pro, Oberdorla, Germa-
ny). All cell lines were incubated in a humidified atmosphere 
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at 37 °C and 5% CO2 (Incubator Galaxy 170 S, New Bruns-
wick Scientific) and passaged thrice weekly using trypsin 
(0.25%, c·c·pro, Oberdorla, Germany) for T24 cells and tryp-
sin-EDTA (0.25%, c·c·pro, Oberdorla, Germany) for HepG2 
and A375 cells. Before conducting toxicity experiments with 
the three cell lines, the thawed cells (HepG2 passage number 
P22, T24 passage number P28, A375 passage number P25) 
were passaged three times. To maintain comparable condi-
tions, no more than ten further passages were performed with 
one cell line. 
Non-essential amino acids were only used for standard cul-
tivation of HepG2 cells. To investigate the effect of NEAA on 
selenosulfate and selenite cytotoxicity and uptake, experi-
ments with HepG2 cells were additionally conducted in MEM 
without NEAA addition and with T24 cells in MEM with 
NEAA supplementation. To let the cells adapt to the modified 
medium, they were passaged for at least three times before 
starting an experiment.  
MTT assay  
For cytotoxicity testing, 5000 cells/well were allowed to at-
tach for 24 h in 96 well plates (Falcon, Becton Dickinson, 
Meylan Cedex, France) and subsequently exposed to seleno-
sulfate (0.17-25 µM) or selenite (0.1-15 µM). For each exper-
iment, selenosulfate and selenite standards were prepared 
freshly, sterile-filtered, and diluted in autoclaved water (Am-
puwa, Fresenius Kabi, Bad Homburg, Germany). All experi-
ments were conducted as triplicate with six equally treated 
wells per replicate (n = 18). For HepG2 cells, the 24 h incuba-
tion experiments were conducted twice (each setup conducted 
in triplicate). In each experiment, six wells were treated with 
the same concentration. After the respective incubation time 
(24, 48, and 72 h for HepG2 and T24 cells, 24 h for A375 
cells), cells were incubated for 2 h with 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; 
Sigma-Aldrich, USA). Afterwards, the formazan crystals were 
dissolved in solubilization solution (10 g sodium dodecyl 
sulfate (Sigma-Aldrich, Steinheim, Germany) dissolved in 
99.4 mL dimethyl sulfoxyde (Sigma-Aldrich, Steinheim, 
Germany) and 0.6 mL acetic acid (VWR PROLAB, Briare, 
France)), and the formazan product was spectrophotometrical-
ly measured at 570 nm (reference wavelength 630 nm) (Infi-
nite 200 PRO, TECAN). Cell viability was calculated by set-
ting the cell viabilities of non-treated cells to 100%. Calcula-
tion of the substance´s inhibitory concentration inducing 50% 
cell viability (IC50) was conducted by fitting an erfc(x) func-
tion to the measured cell viability values as published previ-
ously (Hinrichsen et al. 2014). The lower the IC50 value, the 
more toxic the substance. 
Determination of intracellular Se 
A total of 5·106 cells were incubated for 24 h with fresh 
growth medium containing 1 µM selenite or 1.7 µM selenosul-
fate, respectively. Both selenium compounds were freshly 
prepared. These concentrations were selected because they 
were shown to be non-cytotoxic after 24 h incubation (CV 
98.8 ± 3.7% and 94.9 ± 5.1%, respectively). The exact seleni-
um concentrations in selenosulfate and selenite solutions were 
analyzed by ICP-MS. For better comparability, results are 
reported in ng Se taken up per 106 cells normalized to µM of 
initially applied selenium. The medium was removed after 
24 h and the cells were successively rinsed with Dulbecco’s 
Phosphate Buffered Saline (DPBS, GIBCO), Ampuwa, and 
0.1 mM 2,3-dimercapto-1-propanesulfonic acid sodium salt 
monohydrate (DMPS, Alfa Aesar, Karlsruhe, Germany, purity 
95%) according to a published procedure (Hippler et al. 2011) 
to ensure the absence of extracellular selenium. Cells were 
trypsinized, collected in 2 mL DPBS, and mechanically lysed 
using glass beads (Retsch, Haan, Germany). Selenium uptake 
after 24 h incubation was additionally quantified in HepG2 
cells grown in NEAA-free medium and in T24 cells grown in 
medium supplemented with NEAA. Total selenium concentra-
tions in the cell lysates were determined without any further 
dilution by ICP-MS. 
Statistical analyses 
Separate two-way analyses of variance (ANOVA) were 
used to test for significant differences in the effects of incuba-
tion time and NEAA addition on cell viability curves of the 
two different selenium species. All data met assumptions of 
homogeneity of variance and normal distribution. Statistical 
analyses were performed with SPSS version 21.0 (IBM, Ar-
monk, New York, USA). 
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Results 
Comparing the three investigated cell lines - HepG2, A375, 
and T24 cells -, it becomes obvious that only HepG2 cells 
showed the expected trend of selenosulfate being more toxic 
than selenite (Fig. 1). The IC50 values were 7.1 or 7.8 µM and 
> 15 µM for selenosulfate and selenite, respectively, for a 24 h 
exposure (Table 1). The cell viability curves showed signifi-
cant differences for all selenium concentrations ≥ 3 µM with 
maximal differences up to 50%. For A375 cells, exposure to 
selenosulfate and selenite resulted in comparable cell viability 
curves. Slight differences were observed for the calculated 
IC50 values (6.6 µM for selenosulfate and 4.7 µM for selenite, 
respectively, Table 1) due to large standard deviations in the 
mid concentration range. For T24 cells, the cytotoxicity of 
selenosulfate was lower than that of selenite (IC50 values 6.9 or 
7.0 and 3.5 µM, Table 1) with maximal differences up to 45%. 
It is interesting to note that the cytotoxicity of selenosulfate 
was rather similar for all three cell lines while the cytotoxicity 
for selenite increased in the order HepG2 < A375 < T24 cells 
(Fig. 1). 
 
For the two cell lines with opposing trends of selenosulfate-
selenite toxicity, HepG2 and T24 cells, more detailed investi-
gations were done varying exposure time (24, 48, and 72 h) 
and in the presence or absence of NEAA. For easier compari-
son, Fig. 2 (species comparison), Fig. 3 (time comparison), 
and Fig. 4 (cell comparison) present essentially the same 24 
cell viability curves derived from different combinations of 
these variables. 
Looking at the species comparison graph (Fig. 2) it becomes 
obvious that for HepG2 cells, selenosulfate was always more 
toxic than selenite. The addition of NEAA had no significant 
effect on selenosulfate cytotoxicity (p > 0.19 for all incubation 
times, Table SI-1) and only significant influence on selenite 
cytotoxicity after 48 and 72 h (p < 0.001, Table SI-2). For T24 
cells, addition of NEAA had an important effect: While sele-
nosulfate curves were almost identical with (IC50 6.9/7.0 µM) 
or without NEAA (IC50 6.6 µM), selenite became much less 
toxic in the presence of NEAA (IC50 8.4 µM compared to IC50 
3.5 µM in the absence on NEAA). In fact, with the addition of 
NEAA, selenite was less toxic than selenosulfate for T24 cells 
just as observed for HepG2 cells. Over time (48 and 72 h 
versus 24 h), the cell viability curves for both species became 
more similar, essentially due to a stronger increase in toxicity 
for selenite and a less pronounced increase in toxicity for 
selenosulfate (Fig. 2 c-f). After 72 h, IC50 values were nearly 
identical with 4.3 µM for selenosulfate and 4.2 µM for selenite 
for HepG2 cells and 1.0 µM for both selenosulfate and selenite 
in T24 cells. The absence of NEAA increased cytotoxicity for 
both species in both cell lines with IC50 values being lower 
than in the presence of NEAA (Table 1) (exception for HepG2 
cells after 24 h incubation).  
Fig. 3 shows nicely the time effect, again. Cell viability 
curves for each selenium species are presented separately for 
HepG2 and T24 cells. While for selenosulfate the cell viability 
curves for 24, 48, and 72 h were quite close together for both 
cell lines (Fig. 3 c, d), there was a significant difference be 
tween 24 and 48 h (p < 0.001, Table SI-2) as well as be-
tween 48 and 72 h (p < 0.002) independent of NEAA absence 
or presence for selenite in HepG2 cells (Fig. 3 a). The selenite 
toxicity in HepG2 cells after 24 h of exposure was remarkably 
low with cell viabilities of ≥ 67% even at concentrations of 
15 µM. In T24 cells, selenite after 24 h exposure in the pres-
ence of NEAA was the curve most prominently distinct from 
all others (Fig. 3 b).  
Comparing the general susceptibility of HepG2 versus T24 
cells shows that HepG2 cells are more robust for both species 
and over all exposure times (Fig. 4). It is, however, also obvi-
ous that this difference is even more pronounced for selenite 
than for selenosulfate. Fig. 4 also shows again that addition of 
NEAA has a larger effect on selenite compared to selenosul-
fate, especially for short-term exposure (24 h) and the more 
susceptible T24 cells (Fig. 4 a). 
In contrast to what was observed for HepG2 and T24 cells, 
no cellular Se retention could be determined for A375 cells 
after 24 h exposure to 1 µM selenite or 1.7 µM selenosulfate 
as there was no difference between intracellular selenium 
concentrations of non-treated A375 control cells (0.73 ng/106 
cells) or A375 cells exposed to selenosulfate (0.65 ng/106 
cells) or selenite (0.71 ng/106 cells) (Table 2). However, expo-
sure to low Se concentrations (< 5 µM) were associated with 
cytotoxic effects that were even more pronounced than in 
HepG2 cells (Fig. 1, Table 1). 
For HepG2 and T24 cells, intracellular selenium concentra-
tions were above those of non-treated control cells and there 
was a significant difference for the two selenium species. For 
selenite, uptake was always greater in T24 cells than in HepG2 
cells. The addition of NEAA enhanced the difference between 
the two cell lines with 8.5 ng/106 cells in T24 cells in the ab-
sence of NEAA compared to only 2.7 ng/106 cells in HepG2 
cells in the presence of NEAA. The order of increasing intra-
cellular concentrations corresponds to the increasing toxicity 
and decrea-sing IC50 values (Fig. 4 a). While differences in 
Figure 1: Cell viabilities (CVs) [%] of HepG2, A375, and 
T24 cells after 24 h incubation with selenosulfate 
(0.17-25 µM) and selenite (0.1-15 µM Se), respectively; 
CVs were determined by MTT assay 
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intracellular concentrations were small (maximum differences 
8.5-2.7 = 5.8 ng/106 cells), differences in IC50 values were 
large (> 11.5 µM) (Table 1). For selenosulfate, intracellular 
concentrations showed a wider range between the two cell 
lines with the lowest concentrations of 1.5 ng/106 cells in 
HepG2 cells, interestingly also in the presence of NEAA. 
Uptake in the absence of NEAA was surprisingly lower 
(3.2/2.5 ng/106 cells). The wider range of intracellular seleni-
um after selenosulfate exposure (maximum difference 23.2-1.5 
= 21.7 ng/106 cells) is not reflected in the quite comparable 
cell viability curves (maximum difference of IC50 values 13.8-
6.6 = 7.2 µM) (Fig. 4 b, Table 1). If we compare the effects in 
the “routinely” applied media (i.e. with NEAA for HepG2 and 
without NEAA for T24 cells), intracellular selenite concentra-
tions were lower (2.7 versus 8.5 ng/106 cells) in HepG2 than in 
T24 cells. 
 
 
 
Figure 2: Comparison of selenosulfate and selenite: Cell viabilities (CVs) after seleno-
sulfate (0.17-25 µM) or selenite incubation (0.1-15 µM) in HepG2 (a, c, e) and T24 cells 
(b, d, f) after 24 h (a, b), 48 h (c, d), and 72 h (e, f); in addition to treatment with stand-
ard growth media, HepG2 cells were cultivated and incubated in growth medium 
without NEAA, T24 cells were cultivated and incubated in growth medium with NEAA; 
CVs were determined by MTT assay 
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Figure 3: Comparison of incubation times: Cell viabilities (CVs) after 24 h, 48 h, and 
72 h incubation with 0.17-25 µM selenosulfate or 0.1-15 µM selenite in HepG2 (a, c) and 
T24 cells (b, d); in addition to treatment with standard growth media, HepG2 cells 
were cultivated and incubated in growth medium without NEAA, T24 cells were culti-
vated and incubated in growth medium with NEAA; CVs were determined by MTT 
assay 
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Figure 4: Comparison of HepG2 and T24 cells: Cell viabilities (CVs) after 24 h (a, b), 48 
h (c, d), and 72 h (e, f) incubation with 0.17-25 µM selenosulfate (b, d, f) or 0.1-15 µM 
selenite (a, c, e); in addition to treatment with standard growth media, HepG2 cells 
were cultivated and incubated in growth medium without NEAA, T24 cells were culti-
vated and incubated in growth medium with NEAA; CVs were determined by MTT 
assay 
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Table 1: IC50 values for HepG2, A375, and T24 cells exposed to selenosulfate (0.17-25 µM) 
or selenite (0.1-15 µM) for 24, 48, and 72 h; 24 h experiments with HepG2 and T24 cells 
were conducted twice (I and II); growth conditions were changed to test the influence 
of non-essential amino acids (NEAA), i.e. HepG2 cells were grown without NEAA, T24 
with NEAA addition 
 
 
 
Table 2: Intracellular selenium content [ng Se/106 cells/µM of applied Se] in HepG2, 
A375, and T24 cells; cells were incubated with 1.7 µM selenosulfate or 1 µM selenite for 
24 h prior to mechanical lysis and analysis of total selenium content of the cell lysates 
by ICP-MS. Growth conditions were changed to test the influence of non-essential 
amino acids (NEAA), i.e. HepG2 cells were grown without NEAA, T24 with NEAA        
addition 
 
  
 IC50 [µM]   24 h (I) 24 h (II) 48 h 72 h 
HepG2 + NEAA selenosulfate 7.1 7.8 6.0 4.3 
  selenite >15 >15 11.7 4.2 
HepG2 - NEAA selenosulfate   13.8 4.2 3.4 
  selenite   >15 4.2 3.0 
A375 (no NEAA) selenosulfate 6.6       
  
selenite 4.7 
      
T24 + NEAA selenosulfate   6.6 2.8 2.4 
  selenite   8.4 2.9 2.4 
T24 - NEAA selenosulfate 6.9 7.0 1.5 1.0 
  selenite 3.5 3.5 1.0 1.0 
intracellular Se [ng/10^6 cells/µM of applied Se] + NEAA - NEAA 
HepG2 selenosulfate 23.2 3.2/2.5* 
HepG2 selenite 
HepG2 without selenium addition (control) 
2.7 
1.5 
4.5/4.0* 
 
A375 selenosulfate   0.65 
A375 selenite 
A375 without selenium addition (control)   
0.71 
0.73 
T24 selenosulfate 1.7/1.5* 12.9 
T24 selenite 
T24 without selenium addition (control) 
6.2/2.8* 
 
8.5 
0.5 
*Experiments were conducted in duplicate 
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Discussion 
Based on the results of our study we have to caution that the 
claim of patent US 2010/0172822 that “sodium selenosulfate 
had a much stronger cytotoxicity to tumor cells than sodium 
selenite” (Zhang 2010) cannot be generalized. While seleno-
sulfate was more toxic than selenite in previous cytotoxicity 
tests with tumor cells of the liver (HepG2), the intestine (Ca-
co-2), and the blood (HL60, T lymph adenoma, Daudi) (Zhang 
et al. 2008a), we showed that for tumor cells of the skin 
(A375) and the bladder (T24) this is not the case. 
 Our study showed that the selenosulfate toxicity was simi-
lar between HepG2, A375, and T24 cells (Fig. 1) and largely 
independent of exposure time or absence and presence of 
amino acids, despite great variations in intracellular concentra-
tions. This is in contrast to a previous study (Olm et al. 2009) 
where selenium uptake was found to determine its extent of 
cytotoxicity in different cell lines. What changed among the 
three cell lines was the toxicity of selenite, which was lower 
than that of selenosulfate only for HepG2 cells, but similar to 
and higher than that of selenosulfate for A375 and T24 cells, 
respectively.  
HepG2 cells were generally the least susceptible cell line 
among the three cell lines tested, which is in accordance with 
previous observations from our own studies on cytotoxicity of 
arsenite and thioarsenates (AsS4-nOn3-) (Hinrichsen et al. 
2014). Especially at short exposure times, selenite toxicity to 
HepG2 cells was remarkably low, both compared to selenosul-
fate in HepG2 cells but also to selenite toxicity in A375 and 
T24 cells. Over time, selenite toxicity increased much more 
than that of selenosulfate and for longer exposure times, toxic-
ities for both species became similar. In this context it is inter-
esting to note that the cytotoxicities that Zhang et al. (2008) 
measured after 72 h for HepG2 cells were more comparable to 
what we measured after 24 h already. In the present study 5 
µM selenosulfate resulted in 117% CV and 5 µM selenite 
resulted in 87% CV. In the study from Zhang et al. (2008) 
6 µM selenosulfate resulted in 80% CV and 6 µM selenite 
resulted in 90% CV after 72 h. The difference between both 
studies is that Zhang et al. (2008) used fresh growth medium 
for Se incubation whereas we already grew HepG2 cells in the 
medium 24 h before selenium incubation to maintain the rou-
tine of fresh medium supply as applied during the cell cultiva-
tion. It thus seems that the large difference between selenosul-
fate and selenite toxicity is only a short-term effect, observable 
under optimum conditions - short exposure (24 h in our case) 
or fresh medium (Zhang et al. 2008) - for this specific cell 
line. An obvious explanation might be the very low selenite 
uptake compared to selenosulfate uptake in HepG2 or to sele-
nite uptake in T24 cells. Amino acids had little short-term 
effect on either selenite or selenosulfate cytotoxicity in HepG2 
cells but decreased cytotoxicity slightly for longer exposure 
times.  
For T24 cells, we observed the opposite effect as for HepG2 
cells that selenite was more toxic than selenosulfate. Small 
increases in intracellular selenite concentrations had a much 
higher effect on increasing cytotoxicity both in comparison to 
selenite in HepG2 cells as well as to selenosulfate in T24 cells. 
Over time, the difference between selenite and selenosulfate 
decreased. The addition of NEAA actually even reversed the 
order of toxicity and decreased cellular uptake of selenite. The 
strong effect that NEAA had on T24 cells, but much less so on 
HepG2 cells, could be explained by an effect on the cellular 
transport system xc-. Cellular uptake of selenite was previously 
shown to be highly dependent of the cellular transport system 
xc
-
. Inhibition of the xc- system decreases the extracellular 
cysteine concentration and therefore, less selenite is reduced to 
HSe-
 
leading to decreased uptake and cytotoxicity (Olm et al. 
2009). One amino acid that was contained in the NEAA mix-
ture we applied and for which an effect had previously been 
shown (Olm et al. 2009) is L-glutamic acid. In the form of its 
salt monosodium glutamate it had been shown to prevent toxic 
effects of selenite in lung tumor cells by inhibiting cystine 
transport in the cells (dependent on the xc- transport system) in 
a competitive manner (Gout et al. 1997, Olm et al. 2009). The 
xc
-
 
transport system was reported to be more expressed in 
selenite-sensitive compared to selenite-resistant lung tumor 
cells (Olm et al. 2009). The higher susceptibility of T24 com-
pared to HepG2 cells and the higher selenite uptake in T24 
cells compared to HepG2 cells after 24 h, let us conclude that 
the xc- transport system is more expressed in T24 than in 
HepG2 cells and that this is the reason for the stronger effect 
of presence and absence of NEAA in T24 cells. 
In contrast to selenite, selenosulfate cytotoxicity seemed to 
be less affected by changes in the xc- transport system. This 
could be explained by facilitated uptake because of its reduced 
state. Compared to selenite with an oxidation state of +4, 
selenosulfate has an oxidation state of -1. Furthermore, seleno-
sulfate is synthesized from glutathione and sulfite and non-
reacted excess of any of these two compounds creates a reduc-
tive extracellular microenvironment (Olm et al. 2009). Thiols 
of excess GSH could also facilitate selenium uptake (Bannai 
1986) by formation of further reduced selenium forms in addi-
tion to the formed selenosulfate (Ganyc &Self 2008), e.g. 
selenotrisulfide, selenopersulfide, and hydrogen selenide 
(Bannai 1986). Transport of these reduced compounds could 
occur through anion channels of the plasma membrane as 
reported previously (Conrad &Sato 2012). 
Another observation from our study where the growth me-
dium seemed to have governed the toxicity of selenium spe-
cies for the respective cell line, is A375. In contrast to the 
other two cell lines, intracellular concentrations after both 
selenite and selenosulfate incubation were not distinguishable 
from untreated control cells, but caused comparable toxicities 
as in HepG2 and T24 cells which indicated that A375 cells 
were especially susceptible to selenium. A potential reason 
could be that in contrast to HepG2 and T24 cells, A375 cells 
were cultivated in DMEM medium, which contained about 
twice as much L-cystine compared to MEM medium. We 
hypothesize that the presence of extracellular cystine changes 
the GSH/GSSG ratio, resulting in a decreased defense against 
oxidative stress produced by selenium. Increased toxicity of 
oxidative stress producing H2O2 in the presence of high extra-
cellular cystine levels was already shown for E.coli (Smirnova 
et al. 2005). 
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Experiments with human tumor cell lines are a basic pre-
clinic test in terms of anti-cancer drug permission. As already 
described, compositions of cell growth media differ between 
laboratories leading to limited comparability of cellular uptake 
and cytotoxicity values of substances. The results of our study 
showed that the absence or presence of only one medium 
supplement - NEAA - can completely change the interpreta-
tion of the cytotoxicity for a specific substance.  
Conclusion 
The claim that selenosulfate is more toxic than selenite for 
tumor cells and this could be an additional reason for its pre-
ferred application in anti-cancer therapy compared to selenite, 
cannot be generalized. While this has been demonstrated for 
HepG2 cells, our cell culture study showed that there are cells 
for which selenite is at least as toxic (A375 cells) or more 
toxic (T24 cells) than selenosulfate. Our cell culture studies 
further showed that the choice of growth medium significantly 
influences the outcome of cytotoxicity data. Uptake of selenite 
was shown to be down-regulated by the presence of NEAA, 
especially in selenium-sensitive cells, most likely because L-
glutamic acid inhibited the xc- transport system. The uptake of 
selenosulfate, on the other hand, was generally facilitated by it 
being the more reduced species. We conclude that whether 
selenite or selenosulfate is more toxic to a specific tumor cell 
line depends largely on the sensitivity of each cell line as well 
as the reductive state of the extracellular environment. The 
study shows the importance of considering the effects supple-
ments in cell growth media might have on uptake and cytotox-
icity of different compounds for individual cell lines. 
Supplemental Data 
ANOVA results for selenosulfate and selenite showing 
which cell viability curves are significantly different from 
each other with regard to cell type, exposure time, and pres-
ence or absence of NEAA are available in Online Resource 
Table SI-1 and SI-2.  
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T a b l e  S I - 1  A N O V A  r e s u l t s  f o r  s e l e n o s u l f a t e  s h o w i n g  w h i c h  c e l l  v i a b i l i t y  c u r v e s  a r e  s i g n i f i c a n t l y  ( p  <  0 . 0 5 )  d i f f e r e n t  f r o m  e a c h  o t h e r  w i t h  r e g a r d  t o  c e l l  t y p e ,  
e x p o s u r e  t i m e ,  a n d  p r e s e n c e  o r  a b s e n c e  o f  N E A A  
 
* S i g n i f i c a n t  p  v a l u e s  a r e  m a r k e d  i n  b o l d ;  p  v a l u e s  p r e s e n t e d  i n  p a r e n t h e s e s  i n d i c a t e  s i g n i f i c a n t  d i f f e r e n c e s  b e t w e e n  t w o  i n t e r s e c t e d  c e l l  v i a b i l i t y  c u r v e s ,  w h i c h  d i d  
n o t  d e r i v e  f r o m  i n c u b a t i o n  t i m e  o r  a d d i t i o n  o f  N E A A .  A l l  e x p e r i m e n t s  w e r e  c o n d u c t e d  a s  t r i p l i c a t e  w i t h  s i x  e q u a l l y  t r e a t e d  w e l l s  p e r  r e p l i c a t e ,  i . e .  n  =  1 8  f o r  
A N O V A  a n a l y s i s .  
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Table SI-2 ANOVA results for selenite showing which cell viability curves are significantly (p < 0.05) different from each other with regard to cell type, exposure 
time, and presence or absence of NEAA 
 
*Significant p values are marked in bold; p values presented in parentheses indicate significant differences between two intersected cell viability curves, which did 
not derive from incubation time or addition of NEAA. All experiments were conducted as triplicate with six equally treated wells per replicate, i.e. n = 18 for 
ANOVA analysis. 
 
 
 
24 h 48 h 72 h 24 h 48 h 72 h 24 h 48 h 72 h 24 h 48 h 72 h
2
4
 h
< 0.001 0.005 < 0.001
4
8
 h
< 0.001 < 0.001 < 0.001 < 0.001
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